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INTRODUCTION 
Beef production in the modern-day United States is concentrated in the central 
part of the country. The most common management scheme is to wean calves from brood 
cows and take them immediately to local livestock auctions were they are commingled 
with unfamiliar, aggressive, and possibly diseased animals. Following this initial pooling 
of animals, they may then be sent to several other locations and interact with an 
assortment of cattle before being hauled hundreds to thousands of miles to Great Plains 
cattle feeders. Because of acute stress to animals from this transition, many will develop 
bovine respiratory disease (BRD). 
Bovine respiratory disease is a multifactorial disease that is considered to be the 
most prevalent ailment of cattle in this country.  A recent review of the occurrence of 
BRD in feedlot cattle at the Meat Animal Research Center from 1987 to 2001 revealed 
that 17.0% of the calves were affected annually (Snowder et al., 2006). This respiratory 
disease complex has been shown to affect 90% of unvaccinated calves and 20% of 
vaccinated calves that are placed in a feedlot environment resulting in up to 6.4% 
mortality in untreated animals (Nyamusika et al., 1994). In a survey of feedlot cattle, 
Edwards (1996) found that 67-82% of moribund animals had some form of respiratory 
disease. Prevalence of respiratory disease overshadows other illnesses in feedlot cattle in 
that digestive and miscellaneous disorders contribute only 3-7% and 14-28% of 
morbidity in feedlot cattle, respectively (Edwards, 1996). Furthermore, 44.1% of all 
deaths of feedlot cattle are attributed to BRD. Such high mortality translates to 0.128% of 
feedlot cattle monthly (Smith, 1998).  
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While it is difficult to place an exact figure to economic losses attributable to 
BRD, when one considers that there were 27.6 million cattle on feed in the U.S. in 2007, 
the estimated losses are staggering (USDA, 2007). Nyamusika and coworkers (1994) 
estimated that mild and moderate cases of BRD cost feeders $2.25·per head daily from 
veterinary expenses, while severe cases cost feeders $5.70·hd-1·d-1. This group further 
postulated that BRD led to $8.12 to $29.19/hd for veterinary expenses for vaccinated and 
unvaccinated animals receiving treatment, respectively. These estimates agree with other 
statistics from the 1992-1995 Texas A&M Ranch to Rail program, which state that 
veterinary costs in feedlot cattle range from $20.76-37.90 per animal treated (Smith, 
1998). Additionally, this survey estimates losses from purchase weight to be between 
$0.19-0.35/kg. Treatment of cattle has been shown to decrease carcass quality, and 
economic losses associated with treatment of moribund cattle can lead to approximately 
$31 decrease in carcass value. When cattle are treated two or more times during finishing, 
there is an approximate decrease in the profit margin of $208/animal (Roeber et al., 
2001). With the mortality losses, treatment costs, and decreased carcass quality, it is 
understandable that economic losses associated with BRD exceed $3 billion annually 
(Griffin, 1997). Current market prices, which are near record highs, may make losses 
from BRD much higher than these estimates (Lawrence and Ellis, 2010). 
 Animal health has been shown to have a direct impact on carcass characteristics 
of feedlot cattle. Cattle treated during the finishing period have decreased capacity for 
gaining weight compared to healthy cattle. Gardner and coworkers (1999) found that 
cattle treated two or more times for BRD had average daily gains (ADG) that were 10% 
lower that cattle treated only once. However, a more recent study has shown that during 
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the finishing phase, ADG and feed efficiency increased linearly with increased number of 
times treated (Holland et al., 2010). Equivocal data regarding the impact of lung lesions 
on cattle performance exist. When cattle were stratified by the presence of lung lesions at 
slaughter, Gardner and associates found that cattle having lung lesions had 11% lower 
ADG than cattle not presenting lesions (1999). Interestingly, those researchers found that 
cattle with active lymph nodes at slaughter had 18% lower ADG than cattle with inactive 
lymph nodes. On the other hand, Holland and coworkers found no differences in the 
overall presence of pulmonary lesions at harvest (2010). These groups seem to have 
conflicting results on the effects of BRD on carcass characteristics. While some groups 
have observed lighter hot carcass weights (HCW) and decreased dressing percentages in 
treated calves (Gardener et al., 1999; Roeber et al., 2001), more recent data suggests that 
such differences do not exist in calves fed to a common physiologic endpoint with the 
exception of calves with chronic illness (Holland et al., 2010). The caveat is that in the 
aforementioned study, calves treated 3 times or those with chronic infection were on feed 
19 and 26 days longer, respectively, when compared to those treated on 2 or fewer 
occasions. If one calculates the HCW/total DMI, one finds that calves treated 3 times or 
chronically ill calves have roughly 90% of the efficiency of the others to convert feed to a 
saleable product. 
 Morbidity in feedlot cattle has been shown to have an effect on fat deposition and 
protein accretion. Cattle treated for BRD have less external and internal fat with 
concomitantly lower yield grades scores and decreased longissimus dorsi muscle area 
(Gardener et al., 1999; Roeber et al., 2001). Cattle treated for BRD had lower marbling 
scores when compared to healthy cattle and as a consequence carcasses from these cattle 
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were more likely to receive USDA quality grades of Select and Standard at the expense 
of Choice and Prime grades (Gardener et al., 1999; Roeber et al., 2001; Busby et al., 
2008; Holland et al., 2010).  
RESEARCH OBJECTIVES 
Based on these previous findings, we hypothesize that calves treated for BRD, 
particularly those treated 3 or more times, are less efficient at utilizing metabolizable 
nutrients for tissue accretion thus making them less profitable than healthy calves. The 
first objective of the current research was to evaluate gene expression changes during the 
acute phase response in longissimus dorsi muscle and hepatic tissues when calves are 
experimentally infected with two common BRD pathogens, namely Mannheimia 
haemolytica (formerly Pasteurella haemolytica) and bovine viral diarrhea virus (BVDV). 
This was accomplished by exposing experimental beef steers to a calf persistently 
infected with bovine viral diarrhea viral for 72 hours and subsequently receiving 
intratracheal inoculation of M. haemolytica. Longissimus dorsi and hepatic tissues were 
evaluated by microarray and RT-PCR analysis to identify genes of interest. 
A second objective was to evaluate the differences in expression of these selected 
genes during chronic disease. This was achieved by taking biopsy samples of longissimus 
dorsi muscle and liver at the time of treatment of calves identified as having clinical signs 
of BRD that were treated once, twice, or thrice. Gene expression was determined by RT-
PCR analysis.
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CHAPTER II 
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REVIEW OF LITERATURE 
 As previously discussed, BRD is the most costly animal illness facing the beef 
industry in the United States. Not only are costs for treatment incurred, but significant 
profit losses result from lighter and lower quality beef carcasses. Skeletal muscle tissues 
are the major amino acid reserves in vertebrates. During disease conditions, these muscle 
tissues are called upon to release amino acids making them available for immune 
responses, particularly for acute phase protein production by the liver. Therefore, for 
immune purposes it is necessary for this amino acid mobilization to occur but at the 
expense of the beef product. If it were possible to uncouple the catabolism that occurs in 
skeletal muscle from the anabolism of the liver, there may exist the opportunity to supply 
the liver with amino acids from another source. Research has demonstrated that 
inflammation can lead to nuclear factor-κB (NF-κB) mediated muscle cachexia by 
promoting protein catabolism, suppressing protein synthesis, and inhibiting myoblast 
differentiation, which leads to decreased muscle mass (Hong et al. 2008; Peterson and 
Guttridge, 2008). However, muscle-specific gene targets of NF-κB signaling, which 
would allow for such homeostatic remodeling to occur have not been identified. 
Research and field studies support the idea that bovine respiratory disease can 
become a chronic condition. We have demonstrated that calves chronically ill with BRD 
have poor performance and decrease carcass qualities (Holland et al., 2010). Researchers 
have reported that 37% of steers appearing clinically healthy during the feeding phase 
had lung lesions at slaughter (Gardner et al., 1999). Furthermore, 9% of these animals 
had active bronchial lymph nodes at slaughter (Gardner et al., 1999). This would suggest 
that bovine respiratory disease causes chronic subclinical inflammation.  
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MUSCLE CACHEXIA 
In humans, chronic diseases such as chronic obstructive pulmonary disorder, 
Duchenne muscular dystrophy, sepsis, cancer, acquired immunodeficiency syndrome, 
and chronic renal disease produce severe weight loss and cachexia (Hong et al. 2008; 
Peterson and Guttridge, 2008). Researchers have shown in vivo that inflammation results 
in increased protein degradation in skeletal muscle (Voison et al., 1996; Cai et al. 2004; 
Acharyya et al., 2007). Furthermore, in vitro experiments have shown that protein 
synthesis is attenuated during atrophy (Eley and Tisdale, 2007). 
The protein disequilibrium observed in cachexia has been shown to be mediated 
by NF-κB (Cai et al., 2004; Bakkar et al., 2005; Acharyya et al., 2007). Nuclear factor-κB 
signaling has been identified in diverse cell types and activates several signaling 
pathways; the most well characterized being inflammation and cell survival. In brief, NF-
κB activation occurs through two convergent pathways (Fig. 2.1). The classical pathway 
indicates that multiple extracellular stimuli, such as tumor necrosis factor-α (TNF-α), 
interleukin-1 (IL-1), and lipopolysaccharide (LPS), interact with their cognate receptors 
[TNFR, IL-1R, and Toll-like receptor-4 (TLR4)] leading to downstream signal 
transduction through mitogen-activated protein kinase kinase 3 (MEKK3) and 
phosphorylates the β-subunit of the inhibitor of NF-κB complex kinase (IKK). Activated 
IKK phosphorylates inhibitor of NF-κB (IκB) bound to NF-κB freeing it to be degraded 
through the ubiquitin-proteasome pathway. Upon its release, NF-κB crosses into the 
nucleus where it acts as a transcription factor for multiple genes (Li et al., 2008; Peterson 
and Guttridge, 2008). The alternative pathway is mediated through extracellular stimuli 
interacting with their receptors (e.g. CD40, a costimulatory receptor on antigen 
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presenting cells; B-cell activating factor of the TNF family receptor, BAFFR; or 
lymphotoxin-β receptor, LTβR) to promote signaling through NF-κB-inducing kinase 
(NIK) which acts on IKK-α leading to phosphorylation of p100 (a subunit of IκB) 
causing it to be degraded through the ubiquitin-proteasome pathway resulting in 
transnucleation of NF-κB (Li et al., 2008; Peterson and Guttridge, 2008). 
 Nuclear factor-κB signaling has been shown to increase muscle catabolism by 
inducing proteins in the ubiquitin-proteasome pathway, which is the principle route of 
protein degradation in the cell. Researchers have found that in vivo and in vitro exposure 
to TNF-α resulted in increased ubiquitin mRNA and protein degradation in rat skeletal 
muscle (Garcia-Martinez et al., 1995; Llovera et al., 1997). Others have shown that 
atrogin-1 (a.k.a. muscle atrophy F-box, MAFbx) and muscle RING finger 1 (MuRF-1) is 
a muscle specific ubiquitin-ligase found in atrophying skeletal muscles (Bodine et al. 
2001; Gomes et al., 2001). Inflammatory ligands such as LPS, dexamethasone, and TNF-
α have been shown to upregulate expression of these atrogenes with long-term effects; 
however, inhibition of these pathways does not mitigate their expression (Frost et al., 
2007). Indeed, the anabolic hormone, insulin-like growth factor-1 (IGF-1), could 
suppress atrogin-1, but not MuRF-1 expression (Frost et al., 2007). Proteolysis inducing 
factor (PIF) increases the ‘chymotrypsin-like’ activity of the proteasome in myotubes 
(Whitehouse and Tisdale, 2003). Another ubiquitin-ligase, Nedd4, has been shown to be 
upregulated in atrophying muscle and is specific for suspended muscle (Koncarevic et al., 
2007). Several ubiquitin ligases can be induced during skeletal muscle atrophy and are 
specific for the type of stimuli received. 
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Figure 2.1. Nuclear factor-κB signaling pathways (created by Li et al., 2008). 
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 In chronic inflammation, serum levels of pro-inflammatory cytokines (i.e. TNF-α 
and IL-6) increase and are associated with decreased muscle mass (Tracey et al. 1988; 
Visser et al., 2002). In rats injected with TNF-α, anorexia soon appeared, but whole-body 
protein reserves were depleted significantly more than in pair-fed control rats (Tracey et 
al., 1988). Endotoxin and raised levels of TNF-α and IL-1β lead to decreased levels of 
IGF-I and growth hormone (GH), both of which are involved in myogenesis (Fan et al., 
1995; Fan et al., 1996; Frost et al., 2003). Furthermore, these cytokines decrease IGF-I 
mediated protein synthesis by utilizing ceramide as a second messenger to downregulate 
myogenin and MyoD expression, two myogenic proteins (Strle et al., 2004). It has been 
demonstrated that NF-κB signaling, mediated by PIF and angiotensin II, can affect 
translation efficiency by inhibiting binding of methionyl-tRNA to the 43S ribosome (Eley 
and Tisdale, 2007). To complicate the situation, research suggests that protein 
degradation and decreased protein synthesis are responsible for the increased muscle 
protein turnover during acute sepsis; however, compensatory protein synthesis occurs 
during chronic sepsis with a concomitant increase in proteolysis (Voison et al., 1996).  
 Lastly, pro-inflammatory cytokines, namely TNF-α and IL-1β, can inhibit 
differentiation and decrease protein content of myoblasts through NF-κB transactivation 
(Langen et al., 2001). What is of interest is that NF-κB signaling may be necessary for 
myoblast proliferation. Typically, myoblasts will differentiate into myotubes by fusing 
with existing myofibers, but ablation of NF-κB results in decreased myoblast 
proliferation and differentiation by inducing cyclin D expression and promoting cell 
cycle progression from G1 to S phase (Guttridge et al., 1999). Specifically, NF-κB may 
exert its inhibitory effects during the late stages of differentiation.  YinYang1 (YY1) is a 
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negative regulator of myogenesis and researchers have discovered it is induced by NF-κB 
activation resulting in decreased levels of myofibrillar genes encoding troponins, myosin 
heavy and light chains, and α-actin, thereby preventing maturation into myotubes (Wang 
et al., 2007). Activation of NF-κB has been shown to destabilize MyoD transcripts 
through the inducible nitric oxide synthase-nitric oxide pathway (Sitcheran et al., 2003; 
Di Marco et al., 2005). Under these circumstances, repair of differentiated myofibers 
would be suppressed by NF-κB activation. This was demonstrated by Mourkioti and 
coworkers (2006), who found that inhibiting IKK2 activity improved morphology and 
size of myofibers. Overall, NF-κB activation is necessary for myoblast proliferation, but 
its activity prevents myoblast differentiation and may impair muscle regeneration 
following injury. 
AMINO ACIDS AND PROTEOLYSIS 
 Protein homeostasis is essential to an animal’s health, growth, and maintenance of 
life. Proteins provide the basic elements that provide structure (e.g. collagen), movement 
(e.g. actin and myosin), metabolism (e.g. enzymes), respiration (e.g. hemoglobin), and 
immunity (e.g. immunoglobulins). It has long been known that twenty amino acid species 
are the building blocks of proteins, and these can be stratified into those that are an 
indispensable (essential) part of the diet and those that are dispensable (nonessential), 
which can be made in the body from other precursors given the appropriate nutritional 
environment and stage of development (McNurlan and Garlick, 2000). 
 Since animals have no storage capacity of amino acids, the free amino acid pool is 
essentially the crux of protein homeostasis with inputs coming from the diet (particularly 
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the indispensable amino acids), de novo synthesis, and proteolysis of existing proteins. 
Amino acids exit this pool by incorporation into proteins, catabolism to urea and carbon 
dioxide, or as precursors of signaling molecules (Chaveroux et al., 2010; McNurlan and 
Garlick, 2000). Net protein balance, the difference between protein synthesis and its 
degradation, has been shown to fluctuate relative to consumption of a meal. During the 
absorptive period, plasma amino acid concentrations will rise (especially the branched 
chain amino acids) accompanied by a net uptake of amino acids into skeletal muscle 
(Aoki et al., 1976; Huntington and Prior, 1985). Postruminal supply of amino acids to 
steers fed a protein restricted diet resulted in increased muscle proteogenesis and 
proteolysis, with the net result of increase muscle protein accretion (Reecy et al., 1996). 
Additionally, this research group observed postruminal supplementation of amino acids 
promoted cell cycle progression and proliferation and protein synthesis in myogenic cells 
in vitro.  
In contrast, a negative protein balance can result during the post-absorptive period 
or in response to deleterious situations such as malnutrition, including total amino acid 
deficit, imbalanced amino acid profile, or disease. Prolonged protein deficiency in 
children leads to decreased plasma amino acid, especially the essential amino acids, in 
particular, the branched chain amino acids (Arroyave et al., 1962; Baertl et al., 1974).  
Shortage of amino acids leads to growth arrest attributable to changes in the 
somatomedins (GH, IGF-1, and IGF-2). Animals with severe and moderate malnutrition 
had increased circulating concentrations of GH while concomitantly decreasing plasma 
IGF-1 levels (Breier et al., 1986; Renaville et al., 2002). The stimulatory effects of IGF-1 
can be modulated by expression of IGF binding proteins (IGFBP). Young bulls subjected 
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to prolonged undernutrition exhibited lower concentrations of circulating levels of IGF-1 
corresponding with increased IGFBP-2 levels. Realimentation of this group of animals 
reversed this condition with IGF-1 levels increasing and IGFBP-2 decreasing (Renaville 
et al., 2000). The same trends are apparent in humans with decreases in circulating amino 
acids being responsible for stimulation of IGFBP-1 production and growth arrest (Straus 
et al. 1994). The increase in IGFBP-1 results from the increased expression of GH 
(Chaveroux et al., 2010). Therefore, the growth restriction seen in young malnourished 
animals results from increased GH, which, in turn, increases levels of IGFBP, thereby 
reducing levels of IGF-1 and decreasing its somatotrophic activity. 
Pathological situations such as sepsis, cancer, and injury result in decreases in 
body mass and alterations in metabolism leading to negative nitrogen balance. While 
there is an observable increase in protein synthesis, there exists a concomitant increase in 
proteolysis that outpaces the synthesis. (Wykes et al., 1996; Jahoor et al., 1999; Orellana 
et al., 2004; Mercier et al., 2002; Orellana et al., 2002; Langen et al., 2006; Frick et al., 
2008; Balage et al., 2010) 
MUSCLE GENES 
Glutamine Synthetase 
While there are several gene targets whose expression is characteristically 
changed during muscle atrophy, our interest lies in those involved in proteolysis and 
transducing signals from growth stimulatory mediators. In this review, we present a few 
candidate genes of interest in an effort to understand their possible role in decreasing 
muscle mass in calves treated for BRD. 
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The cachexia associated with activation of the NF-κB signaling pathway could 
explain the decreased muscle mass in calves diagnosed with BRD. Increased protein 
degradation leads to accumulation of intracellular ammonia that must be eliminated. 
Glutamine synthetase (also known as glutamate-ammonia ligase; GLUL) is an ATP-
dependent enzyme that ligates ammonia to glutamate forming glutamine. Glutamine is 
the most abundant free amino acid, but 95% of this amino acid is stored intracellularly, 
with skeletal muscle being its major repository (Stipanik and Watford, 2000). 
Additionally, inflammation depletes muscle glutamine levels by as much as 50% (Calder 
and Yaqoob, 1999). Chakrabarti (1998) discovered that TNF-α stimulated GLUL in a 
dose-dependent manner with maximal stimulation observed at 1,000 units/ml TNF-α 
added to murine skeletal muscle cell lines. That same experiment observed that the same 
concentration of TNF-α increased GLUL in a time-dependent manner. Following 24 
hours of TNF-α stimulation, GLUL activity rose 67% and reached maximum activity by 
48 hours with a 3-4 fold increase. This increase in activity corresponded with increased 
GLUL transcription which peaked with a 90% increase in mRNA at twelve hours and 
only slightly decreased transcripts at 24 hours following TNF- α.  
Glutamine may play a pivotal role in skeletal muscle myopathy observed in cattle 
infected with common BRD pathogens. In vitro and ex vivo research demonstrate that 
glutamine supplementation can increase the phagocytic capabilities of human 
macrophages and neutrophils (Parry-Billings et al., 1990; Furukawa et al., 2000). In 
clinical cases, parenteral supplementation of glutamine can increase intramuscular 
glutamine concentrations and nitrogen balance in post-operative patients (Stehle et al., 
1989). However, Wells and coworkers (1999) demonstrated that production of pro-
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inflammatory cytokines in murine macrophages, namely TNF-α, IL-1β, and IL-6, was 
enhanced by glutamine supplementation in vivo during inflammation in the paws of rats, 
suggesting that increased glutamine exacerbated inflammation; however, those rats 
receiving additional glutamine demonstrated decreased swelling in the affected 
appendage (Nascimento et al., 2005). A survival rodent model demonstrated that 
glutamine supplementation significantly increased the chances of survival (Wilmore and 
Shabert, 1998). 
Adiponectin Receptor 1 
 Adiponectin is one of a class of protein hormones secreted by adipocytes called 
adipokines (Freubis et al., 2001; and Yamauchi et al., 2001). Adiponectin is the most 
abundant adipokine in plasma of humans and rodents, and its concentrations decline in 
models of obesity and type 2 diabetes (Kadowaki and Yamauchi, 2005; Dyck et al., 
2006). Moreover, administration of this adipokine can alleviate hyperglycemia and 
hyperinsulinemia in mouse models of insulin resistance (Freubis et al., 2001; Yamauchi, 
2001). Adiponectin has been shown to increase removal of triglycerides and free fatty 
acids in mice fed a high fat diet (Freubis et al., 2001). This removal was facilitated by an 
increase cellular uptake potentiated by increased gene expression of fatty acid 
transporters (i.e., CD36; Freubis et al., 2001; Yamauchi et al., 2005). In addition, this 
hormone decreased triglyceride content in skeletal muscle by increasing gene expression 
of acyl-CoA oxidase and uncoupling protein 2 and as a result increasing fatty acid 
oxidation by as much as 19% (Freubis et al., 2001; Yamauchi et al., 2001). 
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 The effects of adiponectin are mediated by two integral membrane receptors, 
adiponectin receptor-1 and -2 (ADIPOR1 and ADIPOR2); the former being most 
abundantly expressed in skeletal muscle, and the latter being most prolific in liver 
(Yamauchi et al., 2003). Yamauchi’s group observed that transfection of C2C12 murine 
myocytes with ADIPOR1 increased peroxisome proliferator-activated receptor-α (PPAR-
α) activation, which partially explains the increased fatty acid oxidation that they 
observed. Similarly, ADIPOR1 expression increased the phosphorylation of adenosine 
monophosphate kinase (AMPK), acetyl-CoA carboxylase (ACC), and p38 mitogen-
activated protein kinase (p38-MAPK) which in turn accounts for the increase in glucose 
uptake and fatty acid oxidation (Yamauchi et al., 2003). The phosphorylation of ACC 
would lead to decreases in fatty acid biosynthesis (Tong, 2005). 
 In human in vivo studies, there is no consensus on the effects of glucocorticoids 
on adiponectin levels. Intravenous administration of hydrocortisone resulted in decreased 
plasma concentration of adiponectin in healthy subjects (Fallo et al., 2004). Fallo et al. 
(2004) further observed an inverse relationship between urinary cortisol levels and 
adiponectin levels in plasma of patients diagnosed with Cushing’s syndrome. Conversely, 
a more recent study indicated that oral administration of dexamethasone in both healthy 
and diabetic patients resulted in small increases in plasma adiponectin (Jang et al., 2008). 
In contrast, in vitro research indicates that dexamethasone addition to human adipocytes 
decreased adiponectin release by up to 16% (Degawa-Yamauchi et al., 2005). Additional 
research with 3T3-L1 murine adipocytes has similar findings with a 50% decrease in 
adiponectin mRNA following dexamethasone treatment (Fasshauer et al., 2002). Rodent 
models are equally unclear. In obese and non-obese rats, chronic intraperitoneal injection 
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of hydrocortisone decreased serum adiponectin levels and mRNA in white adipose tissue 
(Shi et al., 2010). Another group observed that adrenalectomy increased adiponectin 
mRNA and serum concentrations in obese mice compared with the sham controls; 
however, in wild-type mice, there was a significant drop in these parameters in the 
adrenalectomized group relative to the sham-operated group (Makimura et al., 2002). 
Less information is available regarding the effects of glucocorticoids on ADIPOR1 
expression. Jang and coworkers (2008), found that ADIPOR1 mRNA expression in 
human skeletal muscle was unaffected by dexamethasone treatment. Glucocorticoid-
mediated suppression of adiponectin may explain the decrease in ADIPOR1. Results 
from a study of lean human subjects found that myotubes stimulated with globular 
adiponectin increased expression of ADIPOR1, but myotubes from obese, diabetic, or 
weight loss subjects were refractory to such stimulation (McAinch et al., 2006). 
Depressed levels of adiponectin induced by glucocorticoid may explain the trend for 
ADIPOR1 suppression in the calves in both treatment groups at the 24H time point.  
Inflammatory cytokines, such as TNF-α, can reduce adiponectin release by 
murine adipocytes in vitro (Degawa-Yamauchi et al., 2005). In human subjects, TNF-α 
neutralization resulted in increased total adiponectin levels in serum by more than 10% 
above baseline (Lo et al., 2007). Anorexia is common among morbid animals, which may 
alter adiponectin effects. Investigators have reported increases in ADIPOR1 transcripts in 
skeletal muscle of fasted mice which were restored to original levels upon re-feeding 
(Tsuchida et al., 2004).  
It may be that effects from the stressful handling conditions and decreases in feed 
intake exacerbate the deleterious effects of BRD. If levels of adiponectin and its receptors 
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are altered during BRD infections, this may explain the reduction in muscle accretion 
often seen in calves treated for BRD. In models of diabetic mice, insulin resistance is 
associated with skeletal muscle atrophy. This muscle wasting is observed with low 
plasma concentrations of adiponectin, which is further implicated in increased levels of 
E3 ubiquitin ligases (i.e. atrogin-1 and muscle RING finger-1) involved in the ubiquitin-
proteasome pathway leading to increased protein degradation (Zhou et al., 2007; Wang et 
al., 2006). 
Thioesterase Superfamily Member 4 
Little is known about thioesterase superfamily member 4 (THEM4) protein, and 
we were unable to find information regarding the effects of stress on its expression. 
THEM4, also known as carboxyl-terminal modulator protein (CTMP), was first 
identified in 2001 as an inhibitor of protein kinase B (PKB/Akt) and was thought to be 
localized to the plasma membrane in various in vitro cell cultures (Maira et al., 2001). 
The kinase activity of PKB/Akt was stimulated by insulin and insulin-like growth factor-
1, but this was abolished by expression of THEM4. Furthermore, this group found that 
THEM4 lessened phosphorylation of glycogen synthase kinase-3β, a downstream target 
of PKB/Akt activity. In contrast, Ono’s group, using similar in vitro modeling, indicated 
that overexpression of THEM4 increase phosphorylation of PKB/Akt in both basal and 
insulin stimulated states (Ono et al., 2007). They observed that THEM4 increased 
phosphorylation of glycogen synthase kinase-3β and demonstrably increased glycogen 
synthesis in 3T3-L1 adipocytes. Additional findings in that report suggest that THEM4 
overexpression may increase cell viability following UV irradiation. 
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 More recent reports indicate that THEM4 is a nuclear encoded protein found in 
the inner membrane and intermembrane space of mitochondria that is released into the 
cytosol following apoptotic signaling (Parcellier et al., 2009; Piao et al., 2009). 
Overexpression of THEM4 resulted in increased incidence of cell death and was integral 
in increasing cleavage of pro-apoptotic enzymes (i.e. caspase-3 and poly ADP ribose 
polymerase). This increased induction of THEM4 delayed phosphorylation of PKB/Akt. 
In addition, mutants of THEM4 that are sequestered in the mitochondria do not affect 
phosphorylation of PKB. THEM4 further demonstrated the ability to sequester heat shock 
protein 70 promoting apoptosis (Piao et al., 2009). Therefore, the majority of the 
evidence suggests that THEM4 is an inhibitor of PKB/Akt that functions to sensitize cells 
to apoptotic stimuli. It is further noteworthy that THEM4/Akt heterodimer is an effective 
thioesterase with particular affinity for medium to long chain fatty acids (Zhao et al., 
2009). Yet with the experimentation performed with this enzyme, relatively little is 
known about its induction and regulation; its effects and responses in muscle tissues have 
not been reported. 
ACUTE PHASE RESPONSE 
 Following breach of host defenses by bacterial and/or viral pathogens, trauma, 
stress, surgery, or cancer, the innate immune system initiates a rapid and potentially 
systemic acute inflammatory reaction. Such a response is termed the acute phase 
response (APR) and usually occurs within the first 48 hours of infection or injury. This 
response is initiated by the production of proinflammatory cytokines (e.g. TNF-α, IL-1, 
and IL-6) by phagocytic immune tissues and leads to fever, anorexia, muscle catabolism, 
coagulation, increased glucocorticoid hormones, changes in liver protein synthesis, and 
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leukocytosis (Jeschke and Herndon, 2004; Gruys et al., 2005; Cray et al., 2009; Eckersall 
and Bell, 2010). While such a response is invaluable to the health of the animal, it can 
have severe growth consequences. If the systemic immune response cannot be regulated 
and becomes chronic, it can be detrimental to the animal by increasing morbidity and 
mortality, organ failure, and risk of sepsis (De Maio et al., 1998; Selzman et al. 1998). 
Hepatic Protein Metabolism 
 The parenchymal cells of the liver are responsible for the production of the acute 
phase proteins (APP). These can be classified into two groups; the positive APPs are 
those that are stimulated and the negative APPs are those that are inhibited during this 
response (Gruys et al., 2005; Cray et al., 2009). The positive APPs are so named because 
they typically increase more than 25% from their baseline values during the APR 
(Eckersall and Bell, 2010). These APPs are induced by pro-inflammatory cytokines and 
can be further categorized into Type I and II depending upon the stimulus. Type I APPs 
are stimulated by the IL-1 like cytokines (i.e. TNF-α, IL-1α, and IL-1β) and include 
haptoglobin and α1-acid glycoprotein. Type II APPs such as α2-microglobulin, 
fibrinogen, and serum amyloid A respond to IL-6 like cytokines (i.e. IL-6 and IL-11; 
Jeschke et al., 2004). While there is a plethora of acute phase proteins identified in other 
species, ruminants, particularly cattle, are unique in that haptoglobin and serum amyloid 
A are the major APPs observed to increase during infections (Cray et al., 2009; Eckersall 
and Bell, 2010).  
Haptoglobin (Hp) has been extensively studied, and its major function is 
somewhat bacteriostatic in that it sequesters iron from free hemoglobin in the blood 
 22 
during inflammation preventing its utilization by pathogens (Peterson et al., 2004). 
Changes in Hp levels have been seen in several bacterial and viral infections, including 
M. haemolytica and Pasteurella multocida, BVDV and bovine respiratory synctial virus 
all of which are common BRD pathogens (Peterson et al., 2004; Eckersall and Bell, 
2010). Normal serum Hp concentration in healthy cattle is less than 20 mg/L, but this can 
increase 100 fold or more and is a useful biomarker for clinical infection (Horadagoda et 
al., 1999, Carter et al., 2002; Nikunen et al., 2007, Aich et al., 2009, Burciaga-Robles et 
al., 2010). Previous research from feedlot and dairy calves showed significant increases 
in Hp, serum amyloid A (SAA), fibrinogen, α1-glycoprotein, and lipopolysaccharide 
binding protein associated with infection of common BRD pathogens (Horadagoda et al., 
1999, Carter et al., 2002; Nikunen et al., 2007). In feedlot conditions, Hp concentration 
was increased in calves diagnosed with BRD and the ratio of Hp to serum amyloid A was 
correlated with the numbers antimicrobial treatments administered to morbid calves 
(Carter et al., 2002). In a similar experimental challenge study, calves were inoculated 
with BVDV and 5 days later infected with M. haemolytica (Gånheim et al., 2003). 
Haptoglobin level increased in all groups compared with controls. In calves inoculated 
with BVDV and M. haemolytica, Hp concentrations increased above baseline (0.13 g/l) 
24 hours following joint infection with concentrations 8.5- to 16.9-fold higher observed 
at 3 to 6 days later and finally returning to baseline 10 to 13 days post-infection with both 
pathogens (Gånheim et al., 2003). Research from our laboratory has shown that 
experimental exposure of beef calves to M. haemolytica resulted in a 10-fold increase in 
serum haptoglobin concentrations 18 hours following bacterial infection, reached 
maximal levels at 40 hours and remained elevated for 4 days (Burciaga-Robles et al., 
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2010). Similarly, Aich and coworkers (2009) experimentally induced BRD in calves with 
bovine herpesvirus-1 (BHV-1) and M. haemolytica four days post viral infection, and 
using 2D-gel electrophoresis, they observed several subunits of haptoglobin protein and 
apolipoprotein A1 were significantly increased in all infected calves (independent of 
subsequent survival) at day 4 following viral infection compared to d 0. 
Serum amyloid A is a second definitive positive APP in cattle and is shown to be 
increased during acute inflammation and BRD (Horadagoda et al., 1999, Nikunen et al., 
2007). In an experimental model of chronic infusion of lipopolysaccharide (LPS) in 
heifers, Werling and associates found that SAA concentration in serum was significantly 
increased at 30 minutes post infusion and reach a plateau at 4.5 hours with an 
approximate 5-fold increase that was sustained through 6 hours post infusion (1996). 
Similarly, others observed that SAA rose steadily following 2 hours of intratracheal 
inoculation with P. haemolytica (Horadagoda et al., 1994). As previously mentioned in 
the Gånheim experiment, SAA levels increased in all groups compared with controls. In 
calves inoculated with BVDV and M. haemolytica, SAA concentration changes were 
biphasic with the first phase 1 to 3 days post-infection of both pathogens with peak levels 
increased approximately 5-fold  above baseline (25.6 g/l).The second phase occurred 5 to 
7 days post infection and was similar in peak concentrations, but was more variable. 
Lastly, SAA values returned to normal levels 10 days post infection with both pathogens 
(Gånheim et al., 2003). 
The picture that emerges from these studies is clear that significant changes in 
protein production occur in the liver, which surely modifies amino acid requirements for 
that tissue. In fact, previous research from our laboratory has demonstrated that during 
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experimental M. haemolytica challenges there is a net uptake of essential and non-
essential amino acids by the liver, resulting in net removal of total amino acids from 
portal blood that is greater than unchallenged control animals (Burciaga-Robles, 2007). 
Further, our group observed significantly increased net hepatic removal of aromatic, 
branched chain, and gluconeogenic amino acids (unpublished data). Waggoner and 
associates experimentally challenged beef steers with endotoxin and plasma 
concentrations of isoleucine and leucine significantly decreased, especially following 4 
hours post-infusion with LPS when compared to their unchallenged counterparts 
(Waggoner et al., 2009). Similarly, clearance kinetics in human subjects intravenously 
perfused with amino acids indicated greater removal of several amino acids in patients 
with microbial sepsis when compared to healthy controls, presumably as a result of 
hepatic extraction (Druml et al., 2001). Notably, branched chain and gluconeogenic 
amino acid clearance was 97% greater in septic patients than in control subjects (Druml 
et al., 2001). Low amounts of branched-chain amino acid transferase in the liver make 
metabolism of branched chain amino acids (BCAA) to their ketoacids negligible since 
perfused liver does not readily metabolize BCAA (Smith and Elia, 1983). Little is known 
of hepatic metabolism of BCAA during acute inflammation; however, it may be that 
these amino acids are incorporated into nascent proteins or involved in signaling protein 
translation (Kimball and Jefferson, 2006). Interestingly, Reeds and co-workers compared 
the amino acid content of major APPs (C-reactive protein, fibrinogen, α1-glycoprotein, 
α1-antitrypsin, SAA, and Hp) and muscle protein and found a significant disparity 
between the two (1994). They calculated the demand for the aromatic amino acids 
(phenylalanine, tyrosine, and tryptophan) would lead to more than twice the amount of 
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amino acids in skeletal muscle to be mobilized to accommodate APP synthesis. This need 
for specific amino acids indicates the detriment that the APR can have on muscle in beef 
cattle. 
Hepatic Energy Metabolism  
 The hypermetabolic state that occurs during acute phase of illness results in 
alterations in carbohydrate and lipid metabolism (Chioléro et al., 1997). 
Lipopolysaccharide depletes carbohydrate stores in animals.  In cattle infused with LPS 
or recombinant bovine TNF-α (rbTNF), there was an initial hyperglycemic state as early 
as 30 min. post-infusion with hypoglycemia occurring at 3 hours and sustaining for 6 to 
10 hours (Werling et al., 1996; Kushibiki et al., 2000). Additionally, Montgomery and 
coworkers (2009) found that heifers treated for apparent BRD had lower glucose levels 
compared with those that were untreated. In rodent models of endotoxin challenge, 
researchers have demonstrated LPS leads to hypoglycemia and hepatic glycogen 
depletion in fasted rodents (McCallum and Berry, 1973; Filkins and Cornell, 1974). 
Furthermore, using radioactively labeled substrates (alanine, pyruvate, and glucose), 
these rodent models established that LPS decreased gluconeogenesis, glycogenesis, and 
glyconeogenesis in vivo. Similarly in vitro enzyme activity and kinetic experiments 
indicate endotoxemia decreased activity and substrate flux of phosphoenolpyruvate 
carboxykinase (PEPCK), the rate limiting enzyme in gluconeogenesis; glycogen 
synthase, the primary enzyme in glycogenesis, and pyruvate kinase (PK), an important 
enzyme in glyconeogenesis (McCallum and Berry, 1973; Jones and Titheradge, 1993).  
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Reduction in these enzyme activities is potentiated by the pro-inflammatory 
cytokines. Tumor necrosis factor-α is a transcriptional regulator of PEPCK gene 
expression in endotoxemic rodents and is capable of repressing glucocorticoid- and 
glucagon/cAMP-mediated induction of this gene (Hill and McCallum, 1991; Hill and 
McCallum, 1992; Waltner-Law et al., 2000). In transition dairy cattle administered daily 
low doses of TNF-α for seven days, glucose-6-phosphatase taken from liver tissues 
decreased 50%. Additionally, PEPCK expression tended to be suppressed by this 
inflammatory cytokine, supporting the fact that gluconeogenesis suppression in cattle is 
similar to that in other species (Bradford et al., 2009). However, these results are 
equivocal given that perfused liver slices taken from dairy cattle in mid-lactation tended 
to exhibit increased conversion of radio-labeled propionate to glucose when LPS was 
administered in vivo. This finding led the authors to conclude that those cattle were in an 
increased gluconeogenic state (Waldron et al., 2003). Surprisingly, these results did not 
correspond with results for other gluconeogenic substrates (lactate and alanine) or with 
plasma glucose levels observed in the animals. 
Other cytokines involved in the APR have been implicated in these changes in 
carbohydrate metabolism. Interleukin-6 mitigated the mRNA transcription and 
abundance, and enzyme activities increase of PEPCK and glucokinase, the initial 
committed enzyme of glycolysis, by glucagon and insulin, respectively, in cultured rat 
hepatocytes (Christ et al., 1994; Christ et al., 1997). In a similar study, IL-1β and TNF-α 
both virtually abrogated the glucagon induction of PEPCK transcription and activity, 
which resulted in decreased glucose formation from radioactive lactate (Christ and Nath, 
1996). These effects on PEPCK appear to be potentiated by posttranscriptional 
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degradation of mRNA transcripts and decreased translation of these genes (Christ et al., 
1994; Christ and Nath, 1996). 
Furthermore, inflammatory cytokines are known to alter glycogen metabolism. In 
rat hepatocytes stimulated with insulin, IL-6 and IL-1β lessened the increase of glycogen 
deposition (Lee et al., 1993; Kanemaki et al., 1998). Further, in these studies, these two 
cytokines were able to inhibit the activity of glycogen synthase and to stimulate glycogen 
phosphorylase activity, thereby attenuating the effects of insulin on these two enzymes 
(Lee et al., 1993; Kanemaki et al., 1998). Kanemaki and coworkers (1998) demonstrated 
that IL-6 was very effective, as it decreased glycogen increase by 30% within 1 hour and 
nearly abolished its increase within 4 hours of cytokine treatment, whereas IL-1β showed 
no significant effects until 4 hours.  
Research has established that inflammatory conditions such as sepsis can increase 
whole body resting energy expenditure (Chioléro et al., 1997). Furthermore, the ability of 
pro-inflammatory cytokines to alter transcription, translation, and activity of metabolic 
enzymes involved in glycolysis, gluconeogenesis, glyconeogenesis, glycogenesis, and 
glycogenolysis. The overall picture is that de novo glucose production and utilization is 
inhibited; similarly, glycogen synthesis is inhibited while its degradation is promoted. 
This shift in carbohydrate mobilization supports the theory that hepatic tissues diminish 
carbohydrate utilization to meet the energy demands of peripheral tissues. With markedly 
increased levels of proinflammatory cytokines in cattle with BRD during the acute phase 
response (Burciaga-Robles, 2010), one can presume this would greatly alter expression of 
metabolic genes in cattle. However, there is no known literature that addresses the effects 
of bovine respiratory disease on specific genes in carbohydrate metabolism. Additional 
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research would be of interest given the important differences in carbohydrate metabolism 
of ruminants compared with monogastric species. 
Increased lipid utilization is a common characteristic in pyogenic bacterial 
infections, particularly those that induce sepsis. These infections increase fatty acid 
oxidation, particularly by peripheral tissues, and decrease glucose usage (Stoner, 1987). 
In lactating cows, LPS administration lead to an increase in non-esterified fatty acids 
(NEFA) within 2 hours of administration with return to basal levels an hour later 
(Waldron et al., 2003). Steiger et al. (1999) used a more prolonged infusion of LPS (100 
min.) to dairy heifers and observed a biphasic response of free fatty acids (FFA) and 
glycerol in plasma. There was an initial increase in occurring within 1 hour of infusion, a 
decrease to levels similar to control heifers by 3 hours, and another peak around 4.5 to 5 
hours post-infusion. Free fatty acids, however, elevated for the duration of the 
observations (22 hours). Recombinant bovine TNF-α given to dairy heifers caused 
similar results. There was an elevation in NEFA as early as 45 min. and persistence for 
up to 24 hours following dosing (Kushibiki et al., 2000; Kushibiki et al., 2002). 
Triglyceride (TG) levels of heifers were lowered 2.5 hours post-infusion with LPS and 
remained low for 10 hours, but surprisingly increased to above control levels at 22 hours 
(Steiger et al., 1999). This response is mediated in part by TNF-α. In studies with 
Holstein heifers, administering rbTNF led to an early increase in TG concentration at 30 
to 45 min. following dosing that was followed by diminished levels at 2.5 hours through 
8 hours after treatment with the cytokine (Kushibiki et al., 2000; Kushibiki et al., 2002). 
LPS administration lessened plasma concentration of β-hydroxybutyrate (BHB) within 2 
hours of infusion (Werling, et al., 1996; Steiger et al., 1999; Waldron et al., 2003). There 
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is a variable longer term response in BHB levels with LPS infusion. Following the initial 
decrease, BHB remained suppressed in lactating cows (Waldron et al., 2003). In studies 
with beef heifers, BHB levels were decreased and remained low for 6 hours following 
infusion (Werling et al., 1996). In contrast, dairy heifers with a similar infusion time, 
exhibited an initial decrease similar to the other studies, but BHB levels increased by 6 
hours post-infusion to match those in healthy control heifers (Steiger et al., 1999). On the 
contrary, in dairy cattle with clinical mastitis, there were no significant changes in NEFA 
or ketone levels, but there were chronic decreases in cholesterol (Huszenicza et al., 
1998). Even with these variable results, it is evident that endotoxin can disrupt fatty acid 
and intermediary metabolism. 
In healthy animals, the liver is actively involved in packaging FFA by producing 
very-low-density lipoproteins (VLDL; Jones, 1982). In rodents treated with endotoxin or 
TNF, there was an increase in triglycerides and cholesterol in serum following 
administration (Feingold and Grunfeld, 1986; Feingold et al., 1992). Further that 
laboratory group observed increased fatty acid and cholesterol content in the liver with 
TNF-α treatment and in vitro analysis of liver explants revealed increased incorporation 
of acetate into fatty acids without concomitant changes in acetate oxidation to carbon 
dioxide (Feingold and Grunfeld, 1986). Interleukin-1 also affects lipid metabolic 
aberrations. Injection of IL-1 into chow-fed and sucrose-fed rats resulted in increased 
serum levels of tritiated TG while decreasing glycerol concentrations, indicating that the 
cytokine stimulated TG secretion by liver while suppressing lipolysis (Feingold et al., 
1990). In addition, they observed that IL-1 injected rats had increased hepatic fatty acid 
and cholesterol content when compared to pair-fed controls (Feingold et al., 1990). 
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Therefore, IL-1 increased fatty acid synthesis and decreased fatty acid catabolism in liver, 
presumably supplying the energy substrate to peripheral tissues. Closely related to this is 
secretion of VLDL. Studies with septic and endotoxemic rats and liver explants indicated 
increased levels and secretion of apolipoprotein B (apoB) protein, which represents an 
increase in VLDL and probable role in the hypertriglyceridemia commonly observed 
with sepsis (Tripp et al., 1993; Aspichueta et al., 2005; Bartolomé et al., 2008). Similarly, 
in vitro stimulation of HepG2 and mouse primary liver cells by IL-1β and IL-6, but not 
TNF-α, resulted in increased mRNA and protein levels of apoB (Yokoyama et al., 1988; 
Bartolomé et al., 2008). 
Many of the changes in intermediary metabolism brought about by the APR and 
several cytokines, including TNF-α, IL-1, and IL-6, are due to changes in gene 
expression in hepatic tissues that alter fatty acid, cholesterol, and sphingolipid 
metabolism as well as the lipoproteins involved in their transport (Khovidhunkit et al., 
2004). This review will focus on the changes in hepatic gene expression with regard to 
fatty acid metabolism. Past research focused on the activity of hepatic enzymes in 
response to TNF-α and showed that the activities of acetyl-CoA carboxylase (ACC) and 
fatty acid synthase (FAS), the rate limiting enzymes of fatty acid synthesis, were 
increased 58% and 35%, respectively, in rats 16 hours after treatment (Grunfeld et al., 
1988). Further, studies demonstrate that such a response was due to a coordinated 
increase in citrate concentrations, an allosteric modulator of ACC, and decrease in acyl-
CoA, an allosteric inhibitor of the same (Grunfeld et al., 1988; Grunfeld et al., 1990). A 
more recent study shows that in vivo stimulation with LPS in rodents, and TNF-α, and IL-
1, but not IL-6 stimulation in Hep3B cell lines suppresses transcription of ACC, FAS, 
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and PK (Feingold et al., 2011). These changes in gene expression were a result in part by 
the reduction of mRNA and protein levels for the transcription factor, carbohydrate 
response element binding protein (ChREBP). Other transcription factors in the liver are 
reduced in response to LPS and other APR cytokines and hormones. Namely, the 
peroxisome proliferator-activated receptors (PPAR)-α and γ are suppressed resulting in 
decreased levels of their target genes, FATP (fatty acid transporter protein), CD36/FAT 
(fatty acid translocase), H-FABP (heart-fatty acid binding protein), and carnitine 
palmitoyl transferase (CPT)-Iα resulting in decreased fatty acid transport into and within 
the liver cell as well as decreased fatty acid oxidation (Khovidhunkit et al., 2004). 
Therefore, during the APR, hepatic tissues increase lipogenesis somewhat independently 
of transcription as a result of allosteric modulators and possibly the stability of key fatty 
acid synthesis enzymes and decrease lipolysis and fatty acid oxidation. This results in 
hypertriglyceridemia and increased VLDL levels that carry the fatty acids to peripheral 
tissues for utilization. 
In summary, the increased demand for amino acids for production of APP by the 
liver are supplied by muscle protein catabolism and amino acid uptake by the liver, 
whereas the nucleotides required for the synthesis of the positive APPs are at the expense 
of the transcription and mRNA degradation of the negative APPs (see Christ et al., 1994). 
Furthermore, the liver likely provides energy substrates to the peripheral tissues in 
exchange for the amino acid substrates needed for protein synthesis.
 32 
CHAPTER III 
 
Transcriptome analysis of muscle tissue from calves infected with bovine viral 
diarrhea virus and Mannheimia haemolytica 
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ABSTRACT 
Bovine respiratory disease (BRD) has been shown to negatively impact carcass 
characteristics by leading to lighter carcasses and poorer carcass quality. To understand 
the effects of BRD on muscle gene expression, 16 crossbred beef steers (280.8 + 32.5 kg) 
were divided into 2 treatment groups: the control group (CON) was not exposed to a calf 
persistently infected with bovine viral diarrhea virus type 1b (PI-BVDV) and received an 
intratracheal dose of isotonic saline; an infected group (INF) was exposed to a PI-BVDV 
calf for 72 h followed by intratracheal inoculation with Mannheimiahaemolytica serotype 
A. Muscle biopsies were taken from the longissimus dorsi prior to exposure to both 
pathogens (PRE) and 24 hours (24H) following inoculation. Total RNA was extracted 
and bovine oligonucleotide microarray hybridization performed on the INF samples (n = 
6). Significance was set at fold change greater than |2.0| and P < 0.05. Microarray results 
were validated using RT-PCR. Bioinformatic pathway analysis was conducted using 
Ingenuity Pathway Analysis software. We observed 28 genes were induced and 104 
genes were suppressed following 24H of dual infection. Pathway analysis revealed a 
network of genes centered on nuclear factor-κB.  PCR results demonstrated that 
glutamine synthetase was significantly induced at the 24H sampling (+2.57 fold, P < 
0.01), but did not differ between treatments (P > 0.10). Adiponectin receptor 1 expression 
tended to be suppressed at the 24H sampling (-2.15; P = 0.08), and there was a significant 
treatment x time interaction (P < 0.05). Direct comparison of the CON and INF groups at 
24H sampling indicated INF was significantly higher in expressing ADIPOR1 (+3.89; P 
= 0.03). In the INF group thioesterase family member 4 was suppressed more than 3 fold 
at the 24H sampling compared to the PRE, although results were not significant (P = 
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0.12). These results indicate that there are no substantive changes that occur in muscle 
tissues of beef calves at 24H post-infection with BVDV and M. haemolytica. Further 
research is needed to understand such physiological changes related to muscle atrophy in 
cattle and to better understand tissue nutrient requirements during morbidity. 
Keywords: beef cattle, bovine respiratory disease, gene expression, skeletal muscle 
INTRODUCTION 
 Bovine respiratory disease (BRD) is considered to be the most prevalent and 
economically impacting disease facing the U.S. beef cattle industry. Estimates suggest 
that BRD affects approximately 20 percent of all feedlot calves in the U.S. and could 
create actual and potential profit losses in excess of $3 billion (Edwards, 1996; Griffin, 
1997; Snowder et al. 2006). The disease complex is multifactorial in its etiology. 
Exposed to stressors such as transportation, dietary and climatic changes, handling, and 
commingling with unfamiliar, aggressive, and/or sick animals can lead to 
immunosuppression in calves sufficient to allow primary infection from viral agents like 
parainfluenza virus 3, infectious bovine rhinotracheitis virus, bovine respiratory syncytial 
virus, and bovine viral diarrhea virus (Lillie, 1974, Fulton et al. 2000). These primary 
viral infections further compromise the calves’ immune systems permitting secondary 
bacterial infections to occur, primarily with Pasteurella spp. like Mannheimia 
haemolytica and Pasteurella multocida (Lillie, 1974).  
 Animal health has been shown to have a direct impact on carcass characteristics 
of feedlot cattle. Gardner and coworkers (1999) showed that cattle treated two or more 
times for BRD had lower average daily gains (ADG) than cattle treated only once. This 
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decrease in weight gain was further exacerbated in cattle with evidence of lung lesions 
and/or active lymph nodes at the time of harvest. These decreases in ADG may translate 
into lighter hot carcass weights and decreased dressing percentages (Gardner et al., 1999; 
Roeber et al., 2001).  This evidence suggests that BRD has long-term effects on muscle 
composition in growing calves. Therefore the objective of this study was to examine the 
gene expression profile of calves acutely infected with common BRD pathogens, namely 
bovine viral diarrhea virus and M. haemolytica. 
MATERIALS AND METHODS 
Cattle Management 
 All procedures performed with the animals were approved by the Institutional 
Animal Care and Use Committee at Oklahoma State University (Protocol # AG075). 
Sixteen crossbred Bos taurus steers (280.8 + 32.5 kg) were procured from the 
university’s research herd, housed at the Nutrition and Physiology Unit, Stillwater, OK, 
and fed a standard growing diet according to the nutrient requirements set forth by the 
National Research Council (NRC, 1996). Steers selected for pathogen challenge (INF) 
were  transported 5.1 km to the Willard Sparks Beef Research Center, Stillwater, OK 
where they were commingled together in a 6 x 10.8-m pen with 2 steers confirmed to be 
persistently infected with bovine viral diarrhea virus type 1b (PI-BVDV) using 
genotyping and immunohistochemistry (Fulton et al., 2006). Following a 72 h exposure 
to the PI-BVDV cattle, these steers were returned to the Nutrition and Physiology Unit. 
Following a 12 h rest period, steers were intratracheally challenged at 0800 h with M. 
haemolytica serotype 1 by inoculation with 10 mL of a solution containing 6 x 109 cfu of 
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bacteria similar to the method described by Dowling et al. (2002). In short, following 
restraint, a broncheoalveolar lavage tube (Bivona Medical Technology, Gary, IN) was 
sterilized with chlorhexidine solution, rinsed with saline, inserted into the nostril, directed 
into the trachea within 2 to 3 cm of the bifurcation allowing challenge material to be 
delivered to both lungs.  M. haemolytica serotype 1 bacteria was grown before the 
challenge and reconstituted as described by Mosier et al. (1998).  The control group of 
steers (CON) was not transported nor exposed to a calf persistently infected with bovine 
viral diarrhea virus type 1b (BVDV) and received an intratracheal dose of 10 mL of  PBS 
solution (pH 7.4; Sigma Aldrich, St. Louis, MO). Subsequently, all steers were housed in 
individual stanchions and remained at the Nutrition and Physiology Unit.  
Biopsy Procedure 
Muscle biopsies from the longissimus dorsi were taken at two time points: prior to 
exposure to both pathogens (PRE) and 24 hours (24H) following joint inoculation (Fig. 
3.1). Infection status was determined by serology (Confer et al.,1995). All CON calves 
showed no titers for either pathogen, while all INF calves in the experiment 
seroconverted for both pathogens (data not shown). Muscle biopsy procedures were 
performed similarly to those described by Meijer et al. (1995). Calves were restrained in 
stanchions and a small area (5 x 5 cm) was clipped approximately 10 cm caudal to the 
last rib and approximately 8 cm lateral to the vertebrae. At 24H, the biopsy site was 
approximately 10 cm distal to the PRE sampling site in the same muscle. To provide 
aseptic conditions, the area was cleaned with iodine soap and rinsed with sterile water. 
Local anesthetic (lidocaine 2%, 3 to 15 mL) was administered subcutaneously in the 
designated area (without making contact with the muscle itself). The area was cleaned a 
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second time with iodine solution and ethanol (75%). A 1-2 cm stab incision was made 
through the skin and a sterile Bergstrom biopsy trochar (7 mm in diameter) was inserted 
into the longissimus dorsi muscle and 100 to 200 mg of tissue was removed and 
immediately placed in liquid nitrogen (Dunn et al., 2003; Pampusch et al., 2003). 
Samples were stored at -80oC until lab analysis was performed. 
RNA Isolation 
 Muscle tissue samples were placed in 2 mL TRIzol ReagentTM (Invitrogen; 
Carlsbad, CA) and centrifuged at 12,000 x g for 15 min. at 4oC. Supernatant was 
collected and phenol-chloroform extraction was performed to isolate total RNA 
according to the manufacturer’s protocol with minor modifications. Briefly, samples were 
allowed to stand at room temperature (23oC) for 5 min. Chloroform was added to the 
samples at 0.2 mL per 1 mL of TRIzol reagent used and samples were allowed to stand 
for 10 min. at room temperature. Samples were then centrifuged at 12,000 × g for 15 min. 
at 4oC. The aqueous phase was collected and RNA precipitated by adding an equal 
volume of absolute isopropanol. Samples were kept overnight at -20oC followed by a 
second centrifugation as previously mentioned. The supernatant was discarded and the 
RNA pellet was washed with 75% ethanol and centrifuged at 12,000 × g for 2 min. The 
ethanol supernatant was removed and samples were allowed to dry at room temperature. 
RNA was suspended using diethylpyrocarbonate treated water (42oC) and concentration 
determined by spectrophotometry (NanoDrop ND-1000; Thermo Scientific; Wilmington, 
DE). Agarose gel (1%) electrophoresis was used to determine RNA integrity. 
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Microarray Analysis 
 Microarray analysis was performed on the PRE and 24H INF muscle samples. 
Aminoallyl-amplified RNA (aRNA) was synthesized according to the protocol of 
TargetAmp™ 1-Round Aminoallyl-aRNA Amplification Kit 101 (EPICENTRE; 
Madison, WI).  First-strand cDNA was synthesized using 500 ng mRNA and a synthetic 
oligo(dT) primer containing a promoter sequence at the 5’ end for a phage T7 RNA 
polymerase and reverse transcribed using SuperScript III Reverse Transcriptase 
(Invitrogen; Carlsbad, CA). From the RNA:cDNA hybrids, the RNA was digested into 
fragments for priming of the second strand synthesis using RNase H. Second strand 
synthesis was performed using the DNA polymerase provided by the manufacturer 
creating a double stranded cDNA complex. This double stranded cDNA was transcribed 
in vitro and 5-(3-aminoallyl)-UTP was incorporated into the nascent strands.  
Aminoallyl-aRNA was purified using RNeasy MinElute Cleanup columns (Qiagen Inc.; 
Valencia, CA) and subsequently labeled using fluorescent dyes: PRE and 24H samples 
were labeled with Alexa Fluor® 555 and 647, respectively (Invitrogen; Carlsbad, CA). 
Dye-coupled aminoallyl-aRNA was purified using the aforementioned purification 
column. Labeled aminoallyl-aRNA was hybridized to bovine genome oligonucleotide 
(70mer) microarray slides (n = 8; Bovine Microarray Consortium; Columbia, MO) and 
incubated at 42oC for 16 to 18 hours. Slides were scanned using the ScanArray Express 
(PerkinElmer; Waltham, MA).  
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Reverse Transcription Polymerase Chain Reaction 
 Microarray results were validated by reverse-transcription polymerase chain 
reaction (RT-PCR). Reverse transcription was performed with 900 ng RNA using 
QuantiTect reverse transcription kit according to the manufacturer’s protocol (Qiagen 
Inc.; Valencia, CA). Concentration of cDNA was assessed by spectrophotometry 
(NanoDrop ND-1000; Thermo Scientific; Wilmington, DE). Quantitative PCR was 
conducted with 100 ng cDNA and using the PerfeCTa® SYBR® Green FastMix® Kit 
(Quanta Biosciences Inc.; Gaithersburg, MD) according to the following reaction 
protocol: cycle 1: (1X) 95ºC for 2 min. 30s; cycle 2: (40X), step 1: 95ºC for 10s, step 2: 
primer-specific temperatures (Table 3.1) for 30s, and step 3: 72ºC for 30s; cycle 3: (81X) 
55 to 95º C for 30s. The reaction was performed and fluorescent intensity measured using 
the BioRad MyiQ™ Real Time PCR Detection System (Bio-Rad Laboratories, Inc.; 
Hercules, CA). Optimal melt temperatures for all primers were determined using a 
temperature gradient qPCR. Amplification efficiency was assessed by performing qPCR 
with a standard curve of serial dilutions of cDNA (Table 3.1). Primer sequences are 
presented in Table 3.1. 
Data Analysis 
Microarray. Microarray images were preprocessed for spot recognition, spot 
correlation with gene array list, and GenePix Results (GPR) files were generated using 
GenePix Pro 5.0 software (Molecular Devices, Sunnyvale, CA).  Signal filtering, 
background noise correction, global intensity Loess normalization, and statistical analysis 
of GPR files (n = 6) were conducted by GenePix Auto Processor 3.2 software (Weng and 
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Ayoubi, 2005; http://darwin.biochem.okstate.edu/gpap). Data were analyzed using log2 
transformation of signal intensities calculated as: M = log2(24H / PRE). Fold change was 
calculated as follows:  for M values ≥ 0, fold change = 2 ^ (M); for M values < 0, fold 
change = (-1) * 2 ^ (M). Differential gene expression was considered to be statistically 
significant if a minimum of 2 spots were represented, the fold change ≥ |2|, and P < 0.05. 
Gene ontology was assigned to each gene according to its biological process or molecular 
function using DAVID Bioinformatics Resources 2008 (Dennis et al., 2003; Huang et al., 
2009; http://david.abcc.ncifcrf.gov/) or KEGG (Ogata et al., 1999; 
http://www.genome.jp/kegg/). A subset of the genes was selected using increased 
stringency (P < 0.01) for pathway analysis using Ingenuity Pathway Analysis Software 
(Ingenuity Systems, Inc.; Redwood City, CA). 
RT-PCR. The experiment was conducted in a completely randomized design 
with infection, time of biopsy, and their interaction used at the treatment effects and 
individual animal within infection x time represented the random effects. Data from RT-
PCR was analyzed as the difference (∆Ct) between the threshold cycle (Ct) for 18S and 
that for gene of interest. ∆Ct values were analyzed using the MIXED procedure (SAS v. 
9.2, SAS Institute Inc.; Cary, NC). Fold change was determined according to the 
following formula: for ∆Ct values < 0, fold change = 2 ^ [(-1) (Least squares mean 24H – 
Least squares mean PRE)]; for ∆Ct values ≥ 0, fold change = (-1) * 2 ^ [(Least squares 
mean 24H – Least squares mean PRE)]. Error bars represent the standard error of the 
mean of the ∆Ct values. Gene expression was considered significantly different at P < 
0.05. 
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RESULTS 
Microarray Analysis 
 Microarray analysis of the entire bovine genome identified 132 differentially 
expressed genes when 24H was compared to PRE in the INF calves (P < 0.05). Among 
the genes (28) that were induced in muscle tissues following 24 h of joint infection of 
BVDV and M. haemolytica, the most affected categories were the cell cycle (14%), 
transcription regulation (11%), amino acid metabolism (7%), inflammation (7%), and ion 
(7%) and protein binding (7%; Fig. 3.2). In the category of suppressed genes (104) with 
known functions, transcription regulation (6%), oxidation/reduction (5%), transport (5%), 
ion binding (4%), protein binding (4%) and ubiquitin-mediated proteolysis (4%) were the 
biological processes most altered (Fig. 3.3). Pathway analysis indicated that the network 
containing the most differentially expressed genes (16) was one involved in cellular 
assembly and organization, skeletal and muscular system development and function, and 
cell death. This network of genes was focused around nuclear factor-κB (Fig. 3.4). 
Microarray Validation 
 Quantitative PCR was normalized to 18S rRNA gene expression. All the results 
presented heretofore will represent the 24H sampling time as compared to the PRE. 
Twelve genes were assayed by RT-PCR to compare results to validate the findings of the 
microarray. Comparison of microarray results with those observed using RT-PCR 
indicates differences in values between the two methods, but of the individual genes 
evaluated, seven shared the same directional change as the findings from the microarray 
analysis. Results indicated there was a tendency for an increase in glutamine synthetase 
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expression (GLUL, + 3.53 fold, P < 0.01) and a tendency for thioesterase superfamily 
member 4 to be suppressed in the 24H group relative to the PRE group (THEM4, -3.45 
fold, P = 0.12). Other genes examined revealed no differences in expression between the 
two biopsy sampling times (Table 3.2).  
Comparison of Infected and Control Groups 
 A subset of genes was analyzed to compare the INF calves with the CON calves 
(Table 3.3). Of note, adiponectin receptor 1 (ADIPOR1) showed no effects due to joint 
infection with M. haemolytica and BVDV (P > 0.15); however, there was a tendency for 
the expression of this gene to be suppressed at the 24H time point compared to the PRE (-
2.15; P = 0.08). Additionally, there was an infection x time interaction for this gene such 
that the CON and INF at 24H were down-regulated compared to the PRE time point of 
the CON group (-5.26, P < 0.01; -1.35, P = 0.05; respectively). Glutamine synthetase 
(GLUL) was unaffected by the treatment conditions (P > 0.15), but was significantly 
induced at the 24H sample collection time (+2.57; P < 0.01). There was no treatment x 
time interaction for GLUL expression (P > 0.15). Similarly, thioesterase superfamily 
member 4 (THEM4) expression was unaffected by treatment or the treatment x time 
interaction (P > 0.15), but its expression was numerically decreased at 24H (-1.38; P = 
0.15). We further compared gene expression of the CON versus INF groups at the 24H 
time point and observed that ADIPOR1 was significantly increased in the INF group 
(+3.89; P < 0.05) while GLUL and THEM4 expression was similar between the two 
groups (+1.57, -1.25; P > 0.15). 
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DISCUSSION 
Research has shown that BRD in feedlot cattle has deleterious effects on carcass 
merit as evidenced by decreased yield grades concomitant with lighter hot carcass 
weights indicating an attenuation of muscle accretion (Garcia et al., 2009; Holland et al., 
2010). Bovine respiratory disease has the potential to become a chronic condition in 
calves. Researchers have reported that 37 to 66% of calves that appeared clinically 
healthy during the feeding phase had lung lesions at harvest (Gardner et al., 1999; 
Holland et al., 2010). Gardner et al. (1999) reported that 9% of these healthy animals 
presented active bronchial lymph nodes at the time of harvest. Because BRD can have 
long term effects in clinically healthy calves, we set out to investigate the changes in gene 
expression of muscle tissues in growing calves during the acute stage of illness to begin 
to elucidate the negative carcass effects seen at harvest in calves treated for BRD. 
Microarray 
Results from this experiment show similarities between results from the 
microarray analysis and RT-PCR. However, 5 of 12 genes had differing directional 
changes. Both procedures have their own limitations. Microarray analysis can be 
influenced by dye imbalances either in efficiency of incorporation and spot intensity or 
location on the slide (Smyth and Speed, 2003; Morey et al., 2006). Results from 
microarray analysis can be a product of random and/or cross hybridization (Morey et al., 
2006). Real-time PCR can amplify non-specific products such as misprimed genes or 
primer dimers (Morey et al, 2006). In general, results from microarray and RT-PCR are 
highly correlated with 67 to 73% of genes evaluated exhibiting similar directional 
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changes in the two techniques (Dallas et al., 2005; Morey et al., 2006). Although the 
percentage of genes that shared similar up- or down-regulation patterns between the 
microarray analysis and RT-PCR (58%) in the current experiment was lower than 
previous experiments, the small pool size of genes evaluated may have allowed for more 
variability. To achieve similar results, only one additional gene would need to share 
similarity of directional expression. There is variability in the degree of gene expression 
change in validating microarray data with that of PCR. Some research has shown that 
expression of at least 1.3-fold in either direction show correlation between microarray 
and RT-PCR (Wurmbach et al., 2003; Moyer et al., 2006). Others have indicated that 
gene expression levels less than 1.5-fold are less reliable (Dallas et al., 2005). Of the 
genes in the current experiment that exhibited dissimilar directional changes, three had 
fold changes as determined by RT-PCR that were less than 1.5-fold which may explain 
the discrepancy. These RT-PCR results do not invalidate those from the microarray; 
however, it should be emphasized that RT-PCR is much more sensitive in quantifying 
mRNA expression when compared to microarray analysis. 
The result of pathway analysis from the current experiment indicates that a 
network of genes centering on NF-κB signaling are induced in muscle tissue of growing 
calves acutely infected with BVDV and M. haemolytica. While we did not specifically 
assay typical genes in NF-κB signaling, the stratification of affected genes by their 
biological process and/or molecular function indicates many of the functions are 
congruent with common effects of such signaling, namely cell cycle, transcriptional 
regulation, inflammation, and proteolysis.  Nuclear factor-κB signaling has been 
identified in diverse cell types and activates several signaling pathways; the most well 
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characterized being inflammation and cell survival. The NF-κB pathway is activated by 
multiple extracellular stimuli, such as tumor necrosis factor-α (TNF-α), interleukin-1 (IL-
1), and lipopolysaccharide (LPS). Nuclear factor-κB signal transduction has been shown 
to increase muscle catabolism by inducing proteins in the ubiquitin-proteasome pathway, 
which is the principle route of protein degradation in the cell. Researchers have observed 
that in vivo and in vitro exposure to TNF-α resulted in increased ubiquitin mRNA and 
protein degradation in rat skeletal muscle (Garcia-Martinez et al., 1995; Llovera et al., 
1997). Inflammatory ligands such as LPS, dexamethasone, and TNF-α have been shown 
to upregulate expression of the genes involved in the ubiquitin-proteasome systems with 
long-term effects (Frost et al., 2007). It could be hypothesized that chronic exposure to 
NF-κB stimulatory mediators leads to the attenuation of muscle accretion seen in beef 
cattle identified with BRD. 
Glutamine Synthetase 
In the microarray, glutamine synthetase expression was increased in steers 
challenged with M. haemolytica and bovine viral diarrhea virus at the 24H time point 
compared to the pre-challenge samples. Glutamine synthetase is an ATP-dependent 
enzyme that ligates ammonia to glutamate forming glutamine. Glutamine is the most 
abundant free amino acid, but 95% of this amino acid is stored intracellularly, with 
skeletal muscle being its major repository (Stipanik and Watford, 2000). Inflammation 
has been shown to deplete muscle glutamine levels by as much as 50% (Calder and 
Yaqoob, 1999). In addition, pro-inflammatory cytokines have shown the ability to 
increase GLUL transcripts and activity 24 h following treatment (Chakrabarti, 1998). In 
the present experiment, the increased expression of glutamine synthetase (GLUL) was 
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not influenced by infection. Instead time of sampling had the greatest effect. In the 
current experiment, GLUL transcripts were increased more than 2.5-fold at 24H 
compared with PRE which was consistent with induction of the gene in rodent models by 
glucocorticoids suggesting that stress may have played a role in the present experiment 
possibly explaining the differences seen between these time points. It is a further 
possibility that there was residual inflammation in the muscle caused by the previous 
sampling, thereby accounting for the increase in GLUL transcripts in the CON group at 
24H compared to PRE.  
It has been well established that glucocorticoids and other stress hormones can 
lead to muscle protein catabolism (Menconi et al., 2007). This is due in part to increases 
in activity of the ubiquitin-proteasome pathway where endogenous proteins are degraded 
(Frost et al., 2007; Menconi et al., 2007). In efforts to deal with the increased ammonia 
from degradation, GLUL is induced to ligate the ammonia to glutamate producing 
glutamine. Dexamethasone administration has demonstrated the ability to increase GLUL 
activity 2-fold by 24H post-injection but can increase mRNA levels by approximately 5-
fold which is greater than the degree of increase obtained in the current study (Max et al., 
1988; Abcouwer et al., 1995). Since muscle catabolism by glucocorticoids and 
inflammation affect similar pathways involved in degradation, it is possible that the stress 
created by prolonged restraint may be masking the effects that inflammation would have 
on GLUL expression in the present study. Experiments under field conditions may be 
necessary to clarify the effects of BRD on GLUL. 
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Adiponectin Receptor 1 
 Results from this experiment indicate that there was no significant effect of 
ADIPOR1 expression associated with infection of two common BRD pathogens. 
Interestingly, there was a sharp decline in ADIPOR1 expression occurring in the CON 
group at 24H compared to the same group at PRE. This decrease in ADIPOR1 transcripts 
may be a result of stress induced by the management of the steers during the study. This 
suppression is difficult to interpret because of equivocal data in the literature. In human 
in vivo studies, there is no consensus on the effects of glucocorticoids on adiponectin and 
its associated receptor. Intravenous administration of hydrocortisone resulted in 
decreased plasma concentration of adiponectin in human subjects (Fallo et al., 2004), 
while others observed dexamethasone slightly increased adiponectin levels (Jang et al., 
2008). Jang et al. (2008) also observed increased levels of glucose and insulin following 
dexamethasone administration to fasting human subjects. Rodent models are equally 
unclear. In obese and non-obese rats, chronic intraperitoneal injection of hydrocortisone 
decreased serum adiponectin levels and mRNA in white adipose tissue (Shi et al., 2010). 
Another group observed that adrenalectomy increased adiponectin mRNA and serum 
concentrations in obese mice compared with the sham controls; however in wild-type 
mice there was a significant drop in these parameters in the adrenalectomized group 
relative to the sham operated group (Makimura et al., 2002). Less information is available 
regarding the effects of glucocorticoids on ADIPOR1 expression. Glucocorticoid-
mediated suppression of adiponectin may explain the decrease in ADIPOR1. Results 
from a study of lean human subjects showed that myotubes stimulated with globular 
adiponectin increased expression of ADIPOR1 (McAinch et al., 2006). On the other 
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hand, Jang and coworkers (2008) observed that ADIPOR1 mRNA expression in human 
skeletal muscle was unaffected by dexamethasone treatment. Depressed levels of 
adiponectin induced by stress may explain the trend for ADIPOR1 suppression in the 
calves in both treatment groups at the 24H time point.  
Surprisingly, when the CON and INF groups were compared at only the 24H time 
point, there was an increase in ADIPOR1 transcripts in the INF group. This may be a 
result of the dramatic decrease of ADIPOR1 expression in the CON. The INF calves in 
this study exhibited significantly higher rectal temperatures and clinical signs as well as 
decreased feed intake compared with the CON group (data not shown). With the higher 
feed intake of CON steers, insulin levels may have been higher than those of the infected 
group. Research suggests that insulin can affect ADIPOR1 expression in a species 
specific manner. A study of fasted mice demonstrated that ADIPOR1 levels can increase 
2-fold following a 48 h fast which is similar to those observed in comparison of CON and 
INF at 24 h. Administration of insulin to C2C12 myocytes in vitro leads to decreased 
mRNA for the receptor (Staiger et al., 2004; Tsuchida et al., 2004). However, these 
results are controversial because similar studies in human subjects indicate that 
ADIPOR1 is positively correlated with insulin levels in the blood (Debard et al., 2004; 
Staiger et al., 2004). Furthermore, infusion of insulin increased ADIPOR1 levels 2-fold in 
human skeletal muscle (Debard et al., 2004). Changes in feed intake and possible changes 
in insulin may explain the changes in ADIPOR1 expression seen in these steers. It may 
also be that genetic variation in the ADIPOR1 gene affected expression values. One steer 
in the study had Ct and ∆Ct values that were just outside of 2 standard deviations, but the 
values for the 18S reference gene were in line with the others which justified including 
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the steer’s data in the analysis. Adiponectin receptors have shown to be highly 
polymorphic in human populations and were related to insulin resistance (Crimmins and 
Martin, 2007). This genetic variation may explain the extreme response by the 
aforementioned steer and seems a more likely explanation for the low levels of 
ADIPOR1 transcripts in the CON group at 24H. 
Thioesterase Superfamily Member 4 
 Evidence from our findings indicates that THEM4 tends to be slightly down-
regulated at the 24H time point in comparison to the PRE time point. Additionally, when 
the PRE and 24H were compared with only the infected animals, there was greater than 3 
fold suppression of the gene. Expression of this gene was not influenced by treatment 
with the pathogens. Little is known about this protein and we were unable to find 
information regarding the effects of stress on its expression. THEM4, also known as 
carboxyl-terminal modulator protein (CTMP), was first identified in 2001 as an inhibitor 
of protein kinase B (PKB/Akt) and was thought to be localized to the plasma membrane 
in various in vitro cell cultures (Maira et al., 2001). Researchers have noted that THEM4 
may be involved in cell survival (Ono et al., 2007). Following apoptotic signaling this 
protein is released into the cytosol, and overexpression of THEM4/CTMP resulted in 
greater incidence of cell death and was integral in increasing cleavage of pro-apoptotic 
enzymes (i.e., caspase-3 and poly ADP ribose polymerase) (Parcellier et al., 2009; Piao et 
al., 2009). Another group demonstrated that THEM4/CTMP is capable of sequestering 
heat shock protein 70 and promoting apoptosis (Piao et al., 2009). Therefore, the 
evidence suggests that THEM4/CTMP functions to sensitive cells to apoptotic stimuli. 
This makes is appear that suppression of the gene may in effect be an attempt to attenuate 
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muscle tissue atrophy, yet with the experimentation performed regarding this enzyme 
relatively little is known about its induction and regulation; its effects and responses in 
muscle tissues have not been reported. 
 Results from the expression changes in the genes previously discussed indicate 
muscle tissue breakdown when steers are stressed, but was not related to BRD at the 
timepoint samples were collected in the present experiment. The suppression of 
ADIPOR1 is indicative of decreased circulating adiponectin and hence decreased insulin 
sensitivity. Such a change leads to muscle atrophy and increased expression of 
components of the ubiquitin-proteasome pathway to mobilize amino acids. These results 
are congruent with the increased transcripts of GLUL, which would be needed to process 
the increased ammonia levels resultant from such proteolysis. Similarly, increased GLUL 
expression may occur in order to supply glutamine for increased nucleotide synthesis for 
transcription of vital survival genes (Stipanik and Watford, 2000). Furthermore, it is 
plausible to suggest that the induction of GLUL is coordinated to meet the demands of 
the immune cells during times of inflammation. It is well established that glutamine 
utilization is increased in proliferating lymphocytes and that such clonal expansion is 
dependent upon glutamine concentrations (Ardawi and Newsholme, 1983; Kew et al., 
1999). In addition, the tissue macrophages would be induced to stimulate phagocytosis of 
cellular debris that inevitably would occur during muscle atrophy. Macrophages have 
high protein turnover and hence high transcriptional activity. It has been demonstrated 
that macrophages have high glutaminase relative to other immune cells indicating high 
glutamine demands for nucleotide synthesis for mRNA production (Newsholme et al., 
1986). 
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What is of equal interest is the association of all 3 genes evaluated, GLUL, 
ADIPOR1 and THEM4, centers on the Akt/protein kinase B (PKB) signaling pathway. 
This kinase transduces signals from several growth factors including insulin and IGF 
(Whiteman et al., 2002; Sen et al., 2003). Akt/PKB signaling has been shown to promote 
cell survival by phosphorylating pro-apoptotic proteins, Bad and FOXO transcription 
factors (Sen et al., 2003). Furthermore, this signaling pathway has been shown to 
promote cell cycle progression (Sen et al., 2003). Akt/PKB plays an important role in 
muscle tissues in response to insulin by inducing GLUT4 translocation to vesicles 
thereby increasing glucose transport, as well as phosphorylating phosphofructokinase and 
glycogen synthase kinase and subsequently increasing glycolysis and glycogen synthesis 
(Whiteman et al., 2002; Sen et al., 2003). Lastly, activation of Akt/PKB modulates 
protein synthesis by promoting translation through activation of the mTOR pathway 
(Whiteman et al., 2002). 
This experiment was intended to identify molecular targets in muscle tissue of 
growing beef calves that are exposed to common respiratory pathogens. The possible 
stress from handling the cattle in our model may have masked some of the effects of 
BRD infection. However, the identification of these molecular targets that may be 
involved in Akt signaling, a pleiotropic pathway affecting energy metabolism, cell 
growth, and survival warrants further investigation. Increased understanding of these 
transcriptional events may allow manipulation of these molecular targets which could 
decrease or ameliorate muscle losses associated with bovine respiratory disease.  
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Table 3.1. Primer sequences, melt temperatures, amplification efficiencies, and standard curve r2 values 
Gene Forward Sequence Reverse Sequence Tm, ºC* Efficiency r2 
18S TTCGAACGTCTGCCCTATCAA GATGTGGTAGCCGTTTCTCAGG 55.0 92.4% 0.998 
ADIPOR1 CCTCCCTCACCCCTGTCCTGA AGGCCCGAGAAAGATGGGACCAG 61.4 100.3% 0.922 
CTSH CCAGGATGGTGACTGCAAG CCTCCTCATCGTTCAGTGTG 61.4 108.3% 0.905 
CWF19L2 TCAGAGGGATGAATGGATGA TCAAGTGCCTGGCTTTTCTC 55.9 111.7% 0.916 
GLUL ACATTGAGGAGGCCATTGAG TTGATGTTGGAGGTTTCGTG 57.5 100.9% 0.975 
HNMT1 GCAATTCCACGGAGCACCAGTGT CCTGCACCACCGCCAATGCTT 61.4 143.5% 0.924 
MAP3K1 AGCAAGCTGAGGGAACTGCAA AGACCACCATGCCCACCACA 61.4 108.5% 0.979 
RBBP6 ATAAGTCGAACTGAACCAGTGATGGG AGCAACGTGTAGAAAAAGTGTGAGA 61.4 118.5% 0.920 
RFXANK ATCTGAGGAAAGGCGACAAC TCAAGCAAGAAGCGGACAG 61.4 100.1% 0.976 
SMAD7 GGAGTCCTTTCTCTCTCAAAGCAC ACGTTGACACTGCTCTTAGCTCAAT 61.4 136.3% 0.962 
SPTBN1 CAAACGGGAGAAGGACAAAG TGTGTTGGTTCTGAGCTTGC 57.1 110.0% 0.972 
THEM4 GGAAATGCCAGAAAACTGAAGAAAGG TCCAAGACAACAGAGGTGAAGGGT 63.3 100.9% 0.886 
TPM4 GTGGCAGCTCTCAATCGAC TCACCTTCATCCCTCTCTCAC 60.3 91.3% 0.963 
* Tm represents the melting temperature used for primer annealing in qPCR reactions. 
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Table 3.2. Comparison of microarray and RT-PCR results for selected genes in calves following 24 hours of joint infection with 
Mannheimia haemolytica and bovine viral diarrhea virus 
  Fold Change  
Gene Symbol Gene Name Microarray RT-PCR Pr > 1* 
ADIPOR1 Adiponectin receptor 1 -6.31 1.14 0.84 
CTSH Cathepsin H 2.09 2.08 0.35 
CWF19L2 CWF19-like 2, cell cycle control (S. pombe) -1.66 -1.11 0.85 
GLUL Glutamine synthetase 2.91 3.53 < 0.01 
HNMT Histamine N-methyltransferase -6.54 -2.39 0.58 
MAP3K1 Mitogen-activated protein kinase kinase kinase 1 2.04 -1.22 0.68 
RBBP6 Retinoblastoma binding protein 6 -2.04 -1.71 0.23 
RFXANK Regulatory factor X-associated ankyrin-containing protein -2.38 2.03 0.38 
SMAD7 SMAD family member 7 -2.20 -2.26 0.21 
SPTBN1 Spectrin, beta, non-erythrocytic 1 5.11 -1.44 0.60 
THEM4 Thioesterase superfamily member 4 5.17 -3.45 0.12 
TPM4 Tropomyosin 4 2.84 1.82 0.45 
*Represents analysis of gene expression changes between PRE and 24H sampling times obtained from RT-PCR. 
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Figure 3.1. Timeline of muscle biopsy and pathogen exposure and inoculation events. 
P.I. = persistently infected. 
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Figure 3.2. Categories of genes upregulated in muscle tissue following 24 hours of joint infection with BVDV and M. haemolytica. 
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Figure 3.3. Categories of genes downregulated in muscle tissue following 24 hours of joint infection with BVDV and M. haemolytica. 
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Figure 3.4. Network of related genes identified by Ingenuity Pathway Analysis in 
microarray experiments conducted with muscle tissue of steers following 24 hours of 
joint infection with Mannheimia haemolytica and bovine viral diarrhea virus compared 
with calves unexposed to pathogens. Red indicates upregulation of gene expression, 
green indicates downregulation of gene expression, and white indicates related genes. 
 
 58 
Figure 3.5. Effects of M. haemolytica and BVDV infection on gene expression compared 
with controls. a,b Groups with different letters differ (P < 0.05). A = ADIPOR1; B = 
GLUL; C = THEM4. 
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CHAPTER IV 
 
Transcriptome analysis of liver tissue from calves infected with bovine viral 
diarrhea virus and Mannheimia haemolytica 
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ABSTRACT 
Bovine respiratory disease (BRD) is the most prevalent ailment of feedlot cattle and 
negatively impacts animal growth and performance and subsequently leads to less 
desirable carcass characteristics. To understand the effects of BRD on liver gene 
expression, 16 crossbred beef steers (280.8 + 32.5 kg) were divided into 2 treatment 
groups: the control group (CON) was not exposed to a calf persistently infected with 
bovine viral diarrhea virus type 1b (PI-BVDV) and received an intratracheal dose of 
isotonic saline; an infected group (INF) was exposed to a PI-BVDV calf for 72 h 
followed by intratracheal inoculation with Mannheimia haemolytica serotype A. Liver 
biopsies were taken from the right side between the 11th and 12th ribs prior to exposure to 
both pathogens (PRE), 12, (12H) and 24 hours (24H) following bacterial inoculation. 
Total RNA was extracted and bovine oligonucleotide microarray hybridization performed 
on PRE and 24H sampling times (n = 6). Significance for the microarray was set at fold 
change greater than |2| and P < 0.001. Quantitative RT-PCR was performed to both 
validate microarray results and to examine gene expression at the indicated time points 
with significance set at P < 0.05. Bioinformatic pathway analysis was conducted using 
Ingenuity Pathway Analysis. Microarray analysis found 44 genes were induced and 45 
genes were suppressed following 24H of dual infection. Pathway analysis revealed that 
lipid metabolism, molecular transport, cellular assembly and organization, carbohydrate 
metabolism, and small molecule biochemistry were the molecular and cellular functions 
most affected in the current experiment. PCR results showed that beta-site APP-cleaving 
enzyme 1 (BACE1) was increased 2.3-fold in INF compared to CON (P < 0.05). S100 
calcium binding protein A8 (S100A8) transcripts were increased 28.9-fold in INF versus 
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CON (P < 0.001), were also increased more than 21-fold in 12H and 24H above PRE (P 
< 0.01), and exhibited an infection × time interaction with INF-12H and INF-24H 
showing mRNA increases of 44- and 42-fold above CON-PRE, respectively (P < 0.01). 
Fatty acid desaturase 2 (FADS2) was suppressed 73.2-fold in INF relative to CON (P = 
0.05) and tended to be down-regulated 29.5- and 95.1-fold at 12H and 24H versus PRE 
(P = 0.09). Gene expression changes in liver are indicative of hepatic inflammation 
which may suggest calves with BRD are susceptible to the development of fatty liver. 
Keywords: beef cattle, bovine respiratory disease, gene expression, liver 
INTRODUCTION 
 Bovine respiratory disease (BRD) remains the most prevalent and economically 
important disease facing the beef industry in the U.S. Older estimates suggest that this 
ailment affects 1 in 5 feedlot calves and potentially causes profit losses in excess of $3 
billion (Edwards, 1996; Griffin, 1997; Snowder et al., 2006). The disease can develop as 
a result of variety of stressors resulting in immune compromise in the calf permitting 
viral infections such as bovine viral diarrhea virus which precede secondary bacterial 
infections by such species as Mannheimia haemolytica and/or Pasteurella multocida 
(Lillie, 1974; Fulton et al., 2000).  
 Morbidity can have deleterious effects on calf performance and carcass 
characteristics (Gardner et al., 1999; Holland et al., 2010). Following bacterial and/or 
viral infections, the innate immune system initiates an acute systemic inflammatory 
response leading to metabolic changes in the liver (Cray et al., 2009; Eckersall and Bell, 
2010). Research from feedlot and dairy calves showed significant increases in hepatic 
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synthesis of acute phase proteins during infection with common BRD pathogens 
(Horadagoda et al., 1999, Nikunen et al., 2007; Burciaga-Robles et al., 2010). Other 
rodent studies indicate decreased gluconeogenesis, glycogenesis, and glyconeogenesis in 
the liver during acute inflammation (McCallum and Berry, 1973; Jones and Titheradge, 
1993). The acute phase response alters intermediary metabolism through changes in 
expression of genes that alter fatty acid, cholesterol, and sphingolipid metabolism as well 
as the lipoproteins involved in their transport (Khovidhunkit et al., 2004). However, no 
research is available to address changes in liver metabolism during BRD in growing beef 
calves. Therefore, the objective of this study was to examine the gene expression profile 
of liver tissue in calves during acute infection with common BRD pathogens, namely M. 
haemolytica and bovine viral diarrhea virus. 
MATERIALS AND METHODS 
Cattle Management 
 All procedures performed with the animals were approved by the Institutional 
Animal Care and Use Committee at Oklahoma State University (Protocol # AG075). 
Sixteen crossbred Bos taurus steers (280.8 + 32.5 kg) were procured from the 
university’s research herd , housed at the Nutrition and Physiology Unit, Stillwater, OK, 
and fed a standard growing diet according to the nutrient requirements set forth by the 
National Research Council (NRC, 1996). Steers selected for pathogen challenge (INF) 
were transported 3.2 miles to the Willard Sparks Beef Research Center, Stillwater, OK, 
where they were commingled together in a 6 x 10.8-m pen with a 2 steers confirmed to be 
persistently infected with bovine viral diarrhea virus type 1b (PI-BVDV) using 
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genotyping and immunohistochemistry (Fulton et al., 2006). Following a 72 h exposure 
to the PI-BVDV cattle, these steers were returned to the Nutrition and Physiology Unit. 
Following a 12 h rest period, steers were intratracheally challenged at 0800 h with M. 
haemolytica serotype 1 by inoculation with 10 mL of a solution containing 6 x 109 cfu of 
bacteria similar to the method described by Dowling et al. (2002). In short, following 
restraint, a broncheoalveolar lavage tube (Bivona Medical Technology, Gary, IN) was 
sterilized with chlorhexidine solution, rinsed with saline, inserted into the nostril and 
directed into the trachea within 2 to 3 cm of the bifurcation allowing challenge material to 
be delivered to both lungs.  M. haemolytica serotype 1 bacteria was grown before the 
challenge and reconstituted as described by Mosier et al. (1998). The control group of 
steers (CON) was not transported nor exposed to a calf persistently infected with bovine 
viral diarrhea virus type 1b (BVDV) and received an intratracheal dose of 10 mL of PBS 
solution (pH 7.4; Sigma Aldrich, St. Louis, MO). Infection status was determined by 
serology (Confer et al.,1995). All CON calves showed no titers for either pathogen, while 
all INF calves in the experiment seroconverted for both pathogens (data not shown). 
Subsequently, all steers were housed in individual stanchions and remained at the 
Nutrition and Physiology Unit.  
Biopsy Procedure 
Liver biopsy sampling was performed similar to that described by Swanson et al., 
2000. In brief, calves were restrained while standing. An area on the right cranial 
abdominal cavity was clipped in such a way as to surround the intercostal space of the 
11th and 12th ribs. The entire surgical area was aseptically prepared by scrubbing the 
designated area thrice with iodine soap, ethanol (75%) solution, and rinsed with sterile 
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water; scrubbing was performed in a circular motion beginning at the center of the focal 
area and moving outward. Following the third wash, the area was cleansed with iodine 
solution using the same scrubbing motion. Next, a local anesthetic (4 to 10 ml of 
lidocaine 2%) was injected subcutaneously and in the intercostal muscle to desensitize 
the surgical area. Following a 3 to 5 minute pause, a stab incision (1 to 2 cm) using a 
scalpel blade was made through the skin. Subsequently, the biopsy needle [12-gauge × 10 
cm with a penetration depth of 22 mm; Bard® Monopty® Biopsy Instrument (C. R. Bard, 
Inc., Covington, GA)] was advanced through the intercostal muscle on the caudal side of 
the 11th rib, through the peritoneum and diaphragm, and into the liver. Further, this 
biopsy instrument had mechanical action such that only liver tissue was taken and 
avoiding contamination from other tissue types. Upon collection of the sample, the 
instrument was retracted and the specimen was placed in a sterile vial, immediately 
placed in liquid nitrogen (-196º C), and stored at -80º C until analysis was performed. 
RNA Isolation 
 Liver tissue samples were placed in 1 ml TRIzol ReagentTM (Invitrogen; Carlsbad, 
CA) and homogenized for 15-30 s on ice (4o C). Supernatant was collected and phenol-
chloroform extraction was performed to isolate total RNA according to the 
manufacturer’s protocol with minor modifications. Briefly, samples were allowed to 
stand at room temperature (23o C) for 5 min. to promote protein dissociation. Chloroform 
was added to the samples at 0.2 ml per 1 ml of TRIzol reagent used and samples were 
allowed to stand for 10 min. at room temperature. Samples were then centrifuged at 
12,000 x g for 15 min. at 4oC. The aqueous phase was collected and RNA precipitated by 
adding an equal volume of absolute isopropanol. Samples were kept overnight at -20 o C 
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followed by a second centrifugation as previously mentioned. The supernatant was 
discarded and the RNA pellet was washed with 75% ethanol and centrifuged at 12,000 x 
g for 2 min. The ethanol supernatant was removed and samples were allowed to dry at 
room temperature. RNA was suspended using diethylpyrocarbonate treated water (42o C) 
and concentration determined by spectrophotometry (NanoDrop ND-1000; Thermo 
Scientific; Wilmington, DE). Agarose gel (1%) electrophoresis was used to determine 
RNA integrity. Samples were treated with DNase (DNase I, Amplification Grade; 
Invitrogen Corp., Carlsbad, CA) to eliminate contamination from genomic DNA 
according to the manufacturer’s protocol. 
Microarray Analysis 
 Aminoallyl-aRNA (aRNA) was synthesized according to the protocol of 
TargetAmp™ 1-Round Aminoallyl-aRNA Amplification Kit 101 (EPICENTRE; 
Madison, WI). First-strand cDNA was synthesized using 500ng mRNA and a synthetic 
oligo(dT) primer containing a promoter sequence at the 5’ end for a phage T7 RNA 
polymerase and reverse transcribed using SuperScript III Reverse Transcriptase 
(Invitrogen; Carlsbad, CA). From the RNA:cDNA hybrids the RNA was digested into 
fragments for priming of the second strand synthesis using RNase H. Second strand 
synthesis was performed using the DNA polymerase provided by the manufacturer 
creating a double stranded cDNA complex. This double stranded cDNA was transcribed 
in vitro and 5-(3-aminoallyl)-UTP was incorporated into the nascent strands. Aminoallyl-
aRNA was purified using RNeasy MinElute Cleanup columns (Qiagen Inc.; Valencia, 
CA). Aminoallyl-aRNA was labeled using fluorescent dyes: PRE and 24H samples were 
labeled with Alexa Fluor® 555 and 647, respectively (Invitrogen; Carlsbad, CA). Dye-
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couple aminoallyl-aRNA was purified using the aforementioned purification column. 
Labeled aminoallyl-aRNA was hybridized to bovine genome oligonucleotide (70mer) 
microarray slides (n = 8; Bovine Microarray Consortium; Columbia, MO) and incubated 
at 42oC for 16 to 18 hours. Slides were scanned using the ScanArray Express 
(PerkinElmer; Waltham, MA).  
Reverse Transcription Polymerase Chain Reaction 
 Microarray results were validated by reverse-transcription polymerase chain 
reaction (RT-PCR). Reverse transcription was performed with 1800 ng RNA using 
QuantiTect reverse transcription kit (Qiagen Inc.; Valencia, CA) according to the 
manufacturer’s protocol. Quantitative PCR was conducted with 100 ng cDNA using the 
PerfeCTa® SYBR® Green FastMix® Kit (Quanta Biosciences Inc.; Gaithersburg, MD) 
according to the following reaction protocol: initial denaturation: 95ºC for 2 min. 30s; 
denaturation: 95ºC for 10s, annealing at 58ºC for 30s, and extension at 72ºC for 30s 
(forty cycles). The reaction was performed and fluorescent intensity measured using the 
BioRad MyiQ™ Real Time PCR Detection System (Bio-Rad Laboratories, Inc.; 
Hercules, CA). Amplification efficiency was assessed by performing qPCR with a 
standard curve of serial dilutions of cDNA (Table 4.1). Primer sequences are presented in 
Table 4.1.  
Data Analysis 
Microarray. Microarray images were preprocessed for spot recognition and spot 
correlation with gene array list and GenePix Results (GPR) files were generated using 
GenePix Pro 5.0 software (Molecular Devices, Sunnyvale, CA). Signal filtering, 
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background noise correction, global intensity Loess normalization, and statistical analysis 
of GPR files (n = 6) were conducted by GenePix Auto Processor (GPAP) 3.2 software 
(Weng and Ayoubi, 2005; http://darwin.biochem.okstate.edu/gpap). Data was analyzed 
with log2 transformation using signal intensities calculated as log2(24H / PRE) (M 
value). Fold change was calculated as follows:  for M values ≥ 0, fold change = 2 ^ (M 
value); for M values < 0, fold change = (-1) * 2 ^ (M value). Differential gene expression 
was considered to be statistically significant if a minimum of 3 spots were represented, 
the fold change ≥ |2.0|, and P < 0.001. Gene ontology was assigned to each gene 
according to its biological process or molecular function using DAVID Bioinformatics 
Resources 2008 (Huang et al., 2009; Dennis et al., 2003; http://david.abcc.ncifcrf.gov/) or 
KEGG (Ogata et al., 1999; http://www.genome.jp/kegg/). Genes were allocated to 
pathways using Ingenuity Pathway Analysis Software (Ingenuity Systems, Inc.; Redwood 
City, CA). 
RT-PCR. The experiment was conducted in a completely randomized design 
with infection (TRT), sampling time (TIME), and their interaction as main effects with 
animal(TRT × TIME) used as the residual error. Data from RT-PCR was analyzed as the 
difference (∆Ct) between the threshold cycle (Ct) for 18S and that for gene of interest. 
Fold change values were analyzed using the MIXED procedure (SAS v. 9.2, SAS 
Institute Inc.; Cary, NC). Fold change was determined using relative quantification, 
otherwise known as the 2-∆∆CT method (Livak and Schmittgen, 2001). Gene expression 
was considered significantly different at P < 0.05. 
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RESULTS 
Microarray Analysis 
 Microarray analysis of the entire bovine genome identified 89 differentially 
expressed genes when 24H was compared to PRE in the INF calves (P < 0.001). Among 
the genes (44) that were induced in muscle tissues following 24 h of joint infection of 
BVDV and M. haemolytica, the most affected categories were protein metabolism and 
modification (16%), immunity and defense (9%), signal transduction (9%), DNA 
processing (7%), intracellular protein transport (7%) and mRNA transcription and 
processing (7%; Fig. 4.1). In the category of suppressed genes (45) with known 
functions, protein metabolism and modification (21%); lipid, fatty acid, and steroid 
metabolism (14%); amino acid metabolism (7%); signal transduction (7%); DNA 
processing (7%); and immunity and defense (7%) were the biological processes most 
altered (Fig. 4.2). Pathway analysis indicated that the network containing the most 
differentially expressed genes (18) was one associated with cancer, reproductive system 
disease, and the cell cycle. Other identified networks were as follows: small molecule 
biochemistry, amino acid metabolism and molecular transport; lipid metabolism, 
molecular transport, and small molecule biochemistry; and lastly, cell-to-cell signaling 
and interaction, cardiovascular system development and function, and cellular movement. 
The top five molecular and cellular functions were lipid metabolism, molecular transport, 
small molecule biochemistry, cellular assembly and organization, and finally, 
carbohydrate metabolism.  
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Microarray Validation 
Quantitative PCR was normalized to 18S rRNA gene expression. All the results 
presented heretofore will represent the 24H sampling time as compared to the PRE in the 
INF steers only. Ten genes were assayed by RT-PCR to compare results with the findings 
of the microarray. Comparison of microarray results with those observed using RT-PCR 
indicates differences in values between the two methods, but of the individual genes 
evaluated, six shared the same directional change as the findings from the microarray 
analysis. Quantitative PCR results indicated there was a an increase in S100 calcium 
binding protein A8 expression (S100A8, + 42.13 fold, P < 0.01) and a tendency for 
suppression of fatty acid desaturase 2 (FADS2, -184.27 fold, P = 0.10) and selenoprotein 
N 1 (SEPN1, -2.34 fold, P = 0.06) in the 24H group relative to the PRE group. Other 
genes examined revealed no differences in expression between the two biopsy sampling 
times (Table 4.2).  
Comparison of Infected and Control Groups 
 A subset of genes was analyzed to compare the INF calves with the CON calves 
(Table 4.3). Of note, β-site APP-cleaving enzyme 1 (BACE1) showed a 2.3-fold increase 
of mRNA transcripts in INF compared with CON (P = 0.03); however, there were no 
effects of TIME or the TRT × TIME interaction on its expression (P > 0.10). S100 
calcium binding protein A8 was significantly up-regulated in INF steers compared to 
CON (28.9-fold; P = 0.0001). Additionally, there was a significant increase due to TIME 
(P = 0.008) with expression being increased at 12H (21.3-fold) and remaining elevated 
through 24H (21.4-fold) compared to PRE. We observed a significant TRT × TIME 
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interaction (P = 0.007) for S100A8 expression with INF-12H and INF-24H having 44- 
and 42-fold increased transcripts in relation to CON-PRE while the other groups were 
similar. Fatty acid desaturase 2 was suppressed in the INF group versus the CON group (-
73.2-fold; P = 0.05). There was a tendency for TIME to affect FADS2 expression (P = 
0.10); 12H and 24H decreased expression by 32.8- and 91.9-fold relative to PRE. There 
was no significant TRT × TIME interaction on expression of FADS2 (P = 0.15). 
DISCUSSION 
 Informative research has been conducted to delineate the negative effects of BRD 
on the performance and carcass merit of feedlot calves (Gardner et al., 1999; Holland et 
al., 2010). In a companion paper, we recently showed that experimental challenge of 
growing beef calves with BRD pathogens resulted in transcriptional changes in muscle 
that indicated muscle breakdown suggesting an acute systemic inflammatory response 
(unpublished data). An important purpose of muscle protein catabolism is to supply 
amino acids for production of acute phase proteins that are induced during infection with 
common BRD pathogens in growing cattle (Horadagoda et al., 1999, Nikunen et al., 
2007; Burciaga-Robles et al., 2010). Further it has been established that an acute systemic 
inflammatory response can alter hepatic metabolism (Cray et al., 2009; Eckersall and 
Bell, 2010). Because the literature was silent regarding gene expression changes in liver 
tissues of growing beef calves with BRD, our goal was characterize the hepatic response 
to acute infection with two common BRD pathogens, BVDV type 1b and M. 
haemolytica.  
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Microarray Analysis 
We observed similar numbers of genes that were up-regulated (44) and down-
regulated (45). Among these there were similar percentages of genes in each group that 
were altered in protein metabolism, immunity, signal transduction, and DNA processing. 
This is expected given that the acute infection promotes expression of the positive acute 
proteins at the expense of the negative acute phase proteins (Gruys et al., 2005; Cray et 
al., 2009; Eckersall and Bell, 2010). The categories of molecular/biological function that 
were most divergent were those for amino acid and fatty acid metabolism. This was 
corroborated by pathway analysis that categorized 16 genes (both induced and 
suppressed) into a network of amino acid metabolism and 12 genes (both induced and 
suppressed) into a network of lipid metabolism. 
Protein production occurring in the liver modifies amino acid requirements for 
that tissue. In fact, previous research from our laboratory has demonstrated that during 
experimental M. haemolytica challenges there is a net uptake of essential and non-
essential amino acid by the liver, resulting in net removal of total amino acids that is 
greater than unchallenged control animals (Burciaga-Robles, 2007). Similarly, clearance 
kinetics in human subjects intravenously perfused with amino acids indicated greater 
removal of several amino acids in patients with microbial sepsis when compared to 
healthy controls, presumably as a result of hepatic extraction (Druml et al., 2001). 
However, catabolism of these extracted amino acids is lowered suggesting that they are 
directed toward incorporation into nascent proteins and/or used in signaling for protein 
translation (Smith and Elia, 1983). 
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The suppression of fatty acid metabolism is more difficult to explain. A recent 
study shows that the acute phase response suppresses transcription of enzymes involved 
in fatty acid synthesis (acetyl-CoA carboxylase, fatty acid synthase, and pyruvate kinase; 
Feingold et al., 2011). These changes in gene expression were a result in part by the 
reduction of mRNA and protein levels for the transcription factor, carbohydrate response 
element binding protein (ChREBP). Other transcription factors in the liver have shown 
to be reduced in response to LPS and other APR cytokines and hormones. Namely, the 
peroxisome proliferator-activated receptors (PPAR)-α and γ are suppressed resulting in 
decreased levels of their target genes, FATP (fatty acid transporter protein), CD36/FAT 
(fatty acid translocase), H-FABP (heart-fatty acid binding protein), and carnitine 
palmitoyl transferase (CPT)-Iα resulting in decreased fatty acid transport into and within 
the liver cell as well as decrease fatty acid oxidation (Khovidhunkit et al., 2004). 
Microarray Validation 
Results from this experiment show some discrepancies between results from the 
microarray analysis and quantitative RT-PCR. These results showed that 70% of the 
genes evaluated by qPCR were in agreement with the microarray. Generally, results from 
these two assays are highly correlated with 67 to 73% or genes evaluated exhibiting 
similar directional changes (Dallas et al., 2005; Morey et al., 2006). These RT-PCR 
results validate those from the microarray and it must be emphasized that RT-PCR is 
much more sensitive in quantifying mRNA expression when compared to microarray 
analysis as seen in the large divergence in expression values of FADS2, MUSTN1, and 
S100A8. 
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Comparison of Infected and Control Groups 
 To follow up on the results from the microarray validation, we compared the 
expression of the genes in the CON and INF groups and the three sampling times to make 
sure that the expression changes seen were a result of the model or the pathogen 
infection. Quantitative PCR uncovered three genes whose expression differed between 
these groups; BACE1, FADS2, and S100A8. In this experiment, β-site APP cleaving 
enzyme 1 (BACE1) was slightly, but significantly up-regulated as a result of the 
infection with the BRD pathogens. This enzyme is an aspartic acid protease and is the 
rate-limiting catalyst involved in the sequential cleavage of amyloid precursor protein 
(APP) into amyloid-β peptide which commonly associated with the pathogenesis of 
Alzheimer’s disease (Cole and Vassar, 2007; Heneka et al., 2010). β-site APP cleaving 
enzyme 1 (also known as Asp2) is thought to be ubiquitously expressed with greatest 
expression in the brain and pancreas, but only slightly in peripheral tissues including liver 
(Vassar et al., 1999; Yan et al., 1999; Lange-Dohna et al. 2003). The preponderance of 
experiments has been conducted in the pathophysiology of neural tissues with a paucity 
of information regarding its role in the normal physiology and much less so in the liver 
(Cole and Vassar, 2007). 
 Research involving neurons, astrocytes, and glial cells demonstrated that BACE1 
transcription can be affected by several inflammatory signals as mediated by a variety of 
transcription factors. One such factor is nuclear factor (NF)-κB. An in vitro experiment 
was conducted to evaluate the role of NF-κB signaling in neurons and astrocytes and 
researchers observed that TNF-α stimulated BACE1 promoter activity and transcription 
through NF-κB subunits binding in the promoter region (Bourne et al., 2007; Chen et al., 
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2011). Other research in in vivo and in vitro experiments with mouse astrocytes 
demonstrated interferon (IFN)-γ stimulated BACE1 mRNA transcription which further 
translated into increased BACE1 protein and increased levels of its cleavage product, 
amyloid-β which was mediated by JAK2 and ERK1/2 signaling whereby phosphorylated 
STAT1 bound BACE1 promoter stimulating its expression (Hong et al., 2003; Cho et al., 
2007; Yamamoto et al., 2007). Interestingly, IFN-β stimulation increased BACE1 protein 
expression in a time-dependent manner, where BACE1 expression increased to plateau 
levels at 12H and only slightly increased until 24H (Yamamoto et al., 2007). This 
corresponds with the BACE1 transcription on our study, where its expression peaked at 
12H and remained elevated at 24H.  
 The BACE1 protein has been shown to cleave other protein products involved in 
the immune response such α2,6-sialyltransferase (ST6Gal I), which was identified as 
upregulated by our microarray analysis (Cole and Vassar, 2007). This substrate is 
important in that it is highly expressed in the liver and indeed the majority of its secretion 
is by the liver (Kitagawa and Paulson, 1994). Furthermore, ST6Gal I secretion is 
promoted during the acute phase response by the activity of IL-6 (Kaplan et al., 1983; 
Dalziel et al., 1999). In a series of experiments, one research group demonstrated that 
BACE1 may play a role in the acute phase response. First, in an in vitro transfection 
study where BACE1 gene was over-expressed, there was a significant increase in 
secretion of ST6Gal I (Kitazume et al., 2001). Later, an in vivo study showed knockout 
mice for BACE1 had reduced plasma concentrations of ST6Gal I compared to wild-type. 
Conversely, over-expression of BACE1 lead to increased ST6Gal I levels in plasma 
(Kitazume et al, 2005). In addition, that research group found that there was increased 
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ST6Gal I activity in plasma of rats known for hepatic pathology. This activity was 
propagated by increased BACE1 mRNA while ST6GAI transcription remained stable 
(Kitazume et al., 2005). In their most recent experiment, those researchers found 
increased levels of ST6GalI in plasma were correlated to increased levels of the 
haptoglobin and α2-macroglobulin in response to hepatic injury (Kitazume et al., 2009). 
Therefore, in summary, one can hypothesize that the BACE1 mRNA increase in our 
experiment is a result of pro-inflammatory signaling involved in the acute phase response 
to stimulate ST6Gal I levels in plasma. However, with limited research of this gene in 
peripheral tissues, additional research would be needed to clarify its role in the hepatic 
response to inflammation and other potential cleavage products. 
 A second marker of hepatic inflammation was evidenced by the significant 
increase (40-fold) in S100A8. This protein was originally discovered in granulocytic cells 
and was considered to have antimicrobial activities (Dale et al., 1983; Steinbakk et al., 
1990). S100 calcium binding protein A8 along with its homolog, S100A9, have been 
shown to account for 30-45% of the cytosolic proteins in granulocytes (Dale et al., 1983). 
Abundant research has demonstrated the S100A8/S100A9 heterodimeric complex is 
secreted in inflammatory lesions and may function as a chemoattractant for infiltrating 
leukocytes, particularly neutrophils, in response to pro-inflammatory cytokines (Xu and 
Geczy, 2000; Nacken et al., 2003; Gebhardt et al., 2006). In fact, microscopy studies 
have evidenced significant neutrophil infiltration in the sinusoids and parenchyma of the 
liver during endotoxic shock and promotion of hepatocellular injury (Jaeschke et al., 
1991; Chosay et al., 1997). A more recent study using immunohistochemistry 
demonstrated these infiltrating neutrophils to be highly expressive of S100A8/S100A9 
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(Koike et al., 2011). Additionally, high levels of S100A8 have been shown to increase 
death rates in endotoxic mice (Vogl et al., 2007) and are inversely related to survival of 
septic human patients (Payen et al., 2008). It is worth mentioning that S100A8/S100A9 
heterodimer is capable of binding the polyunsaturated fatty acids, α-linolenic, γ-linolenic, 
and arachidonic acid (AA), with the latter having a higher affinity for the heterodimer 
than the former two (Kerkhoff et al., 1999). Further research by that group indicated that 
S100A8/S100A9 functions as an extracellular transporter of AA effectively propagating 
its uptake by FAT/CD36 at the plasma membrane of human umbilical vein endothelial 
cells (Kerkhoff et al., 2001). Notably, this transporter is known to be induced by 
endotoxin, TNF, and IL-1 (Memon et al., 1998). To summarize, the increased S100A8 
expression strongly suggests infiltration of neutrophils into the liver of beef steers during 
the acute phase response to BRD pathogens. In addition, the fatty acid binding properties 
of S100A8 are suggestive of increased fatty acid uptake and accumulation into the liver. 
 Pathway analysis of the current experiment indicated that fatty acid metabolism 
was affected by bacterial and viral infection in steers challenged with BRD pathogens. 
Much research has been conducted examining the effects of inflammation on lipid 
metabolism. During acute inflammation, hepatic tissues shift priority from fatty acid 
oxidation and lipolysis to increasing fatty acid, triglyceride, and cholesterol content 
(Feingold and Grunfeld, 1986; Feingold et al., 1992). Much of the changes in 
intermediary metabolism brought about by the APR are due to changes in gene 
expression in hepatic tissues that alter fatty acid, cholesterol, and sphingolipid 
metabolism brought about by several cytokines including TNF-α, IL-1, and IL-6 
(Khovidhunkit et al., 2004). The effects of these cytokines are mediated by changes in 
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transcription factors for genes involved in fatty acid metabolism including peroxisome 
proliferator-activated receptors α which leads to changes in expression of their target 
genes (Khovidhunkit et al., 2004; Kim et al., 2007).  
 Results from the current experiment indicated dramatic changes in the expression 
of FADS2 gene suggesting changes in fatty acid desaturation congruent with the universal 
changes in hepatic lipid metabolism. This gene encodes the sequence for fatty acid 
desaturase 2 protein, more commonly referred to as ∆-6 desaturase (D6D), which is 
highly expressed in the liver (Cho et al., 1999). This enzyme catalyzes the desaturation of 
linoleic and α-linolenic acids to such polyunsaturated fatty acids as arachidonic (AA), 
eicosopentaenoic (EPA), and docosahexaenoic (DHA) acids (Nakamura and Nara, 2004). 
It has been well documented that these fatty acid products mediate the inflammatory 
response. Arachidonic acid promotes inflammation by its derivative eicosanoids, while 
the n-3 series fatty acids, EPA and DHA, can suppress the inflammatory response 
(Chapkin et al., 2009). However, it must be noted that these results are predicated upon 
dietary supplementation of EPA and DHA well above the levels that can be produced by 
the host tissues in vivo (Chapkin et al., 2009).  
We were unable to find experimental results that describe the direct response of 
FADS2 gene expression to the proinflammatory signaling. However, there is evidence 
that transcription factors for the gene of interest are affected by inflammatory signaling. 
Research demonstrates that FADS2 gene possesses an enhancer element for both PPARα 
and sterol regulatory element binding protein 1 (SREBP) that when manipulated can 
affect mRNA levels for this gene in a fashion similar to their own expression (Matsuzaka 
et al., 2002; Tang et al., 2003). Proinflammatory signals associated with the acute phase 
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response, namely LPS, TNF-α, and IL-1, can suppress expression of PPARα and thereby 
decrease its transcriptional activity and mRNA levels of its target genes involved in fatty 
acid oxidation in hepatic cells (Beigneux et al., 2000; Kim et al., 2007). Moreover, 
SREBP-1c, a reciprocal transcription factor known to increase fatty acid synthesis, has 
been shown to respond to LPS and TNF- α by increased mRNA levels in mice and was 
associated with hepatic steatosis (Endo et al., 2007). Moreover, suppression of FADS2 
gene expression has been observed in rodents susceptible to fatty liver (Hall et al., 2010). 
Based on these results one could conclude that the SREBP-1 is being induced thereby 
leading to the suppression of FADS2 expression. In addition, these previous studies 
reporting changes in FADS2 expression less than 10-fold; our results indicate a much 
more pronounced suppression of polyunsaturated fatty acid metabolism in BRD 
challenged steers during the acute phase response.  
In cattle, very little is understood about the FADS2 gene expression in liver. Two 
microarray studies of hepatic tissues during experimentally induced ketosis in dairy cows 
revealed alterations in expression of genes involved in intermediary metabolism (Loor et 
al., 2007; McCarthy et al., 2010). Severe negative energy balance in high-yielding dairy 
cows decreased FADS2 expression by 4.6 and 8.7 fold compared to lactating cows with 
mild negative energy balance in two independent studies (Loor et al., 2007; McCarthy et 
al., 2010). Hepatic lipidosis is often associated with ketosis in cattle and has similar 
pathognomonic characteristics, e.g. increased concentrations of non-esterified fatty acids 
and ketones in blood, increased triglyceride content, and proinflammatory cytokines, and 
can itself have prolonged deleterious consequences to animal health (Bobe et al., 2004). 
Therefore, it could be that the severe decrease in FADS2 expression during the acute 
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phase response in steers challenged with BRD pathogens is indicative of changes in 
intermediary metabolism congruent with fatty liver syndrome. 
One can conclude from the inflammatory markers induced during acute BRD 
infection that significant hepatocellular injury is occurring. It is possible that neutrophil 
infiltration and its cytotoxic products damage parenchymal cells during this time period. 
It is also of interest to note the relationship of a major neutrophil marker and shifts in 
fatty acid metabolism that occur during the APR. S100A8 and FADS2 genes both were 
significantly altered as a result of the experimentally induced inflammation in the liver of 
beef steers. The potential mobilization of fatty acids from the peripheral tissues, 
commonly associated with acute inflammation, leading to the suppression of fatty acid 
desaturation and binding proteins, such as S100A8, may lead to accumulation of fatty 
acids in the liver promoting lipidosis. This is of importance to beef producers because 
research has clearly established changes in the abundance of fat in peripheral tissues from 
calves treated for BRD. No research can be found evaluating the role of fatty liver in 
growing cattle, but research in dairy cows has shown fatty liver syndrome to promote 
morbidity and mortality in dairy cows and it can persist for weeks to months (Gerloff et 
al., 1986; Bobe et al., 2004). Further research is merited to evaluate fatty liver and bovine 
respiratory disease. 
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Table 4.1. Primer sequences, amplification efficiencies, and standard curve r2 values 
Gene Forward Sequence Reverse Sequence Efficiency r2 
18S TTCGAACGTCTGCCCTATCAA GATGTGGTAGCCGTTTCTCAGG 92.4% 0.998 
BACE1 CCCTAGTGAAGCAGACCCACGT ATGCTCCCTCCAACTGAGGCCA 98.7% 0.967 
FADS2 GGAACCATCGCCACTTCCAGCA TCTTGCCGTACTCAATGGGCTGC 103.7% 0.972 
MRPS GCTGTTTTCCGTGCGAAGCC CAAGGCGGCTCCCGAAGATGTA 104.4% 0.995 
MUSTN1 GCTCAGGAAGCCCCCATCAAGA TGCTCACACTCCCGCATGACCT 106.5% 0.968 
ORP AATGACAACACCGCCACAGCCC AGTGCTGCCTGAGCCCATGT 109.3% 0.997 
QRSL1 AGCAGCGGCAACTGACCTTTCTG CAACATGATCCTCGTGCCCCGT 98.8% 0.989 
S100A8 AGGATGCGGACACTTGGTTCAAA GCCCACCTTTATCACCAGCACG 97.4% 0.994 
SEPN1 TGGCTACCTGTCCAACAACCGC AGGGGCAAAACGGGTCTTCACG 102.1% 0.933 
SIAE AGTGCAGGGGGTTTTGGTCTGT TGGCTCTGGGTGTGCCGTAA 110.2% 0.977 
WDR91 AGGACCACGGCAAGGAACGGAA AGCTTCGGGCTTCTTCTCCGCA 95.6% 0.995 
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Table 4.2. Comparison of microarray and RT-PCR results for selected genes in liver tissue of beef calves following  
24 hours of joint infection with Mannheimia haemolytica and bovine viral diarrhea virus 
  Fold Change  
Gene Symbol Gene Name Microarray RT-PCR Pr > 1* 
BACE1 β-site APP-cleaving enzyme 1 -6.63 +1.81 0.41 
FADS2 Fatty acid desaturase 2 -3.98 -184.27 0.10 
MRPS2 Mitochondrial ribosomal protein S2 +2.79 +1.81 0.62 
MUSTN1 Musculoskeletal, embryonic nuclear protein 1 +2.65 +30.26 0.13 
ORP Oxygen regulated protein +10.71 +8.07 0.12 
QRSL1 Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 -5.03 -0.66 0.70 
S100A8 S100 calcium binding protein A8 +3.97 +42.13 < 0.01 
SEPN1 Selenoprotein N, 1 +2.79 -2.34 0.06 
SIAE Sialic acid acetylesterase -4.01 -3.23 0.18 
WDR91 WD repeat domain 91 -3.71 0.71 0.79 
*Represents analysis of gene expression changes between PRE and 24H in INF calves obtained from RT-PCR. 
 82 
Table 4.3. Comparison of RT-PCR results for selected genes in calves following 24 hours of joint infection with Mannheimia 
haemolytica and bovine viral diarrhea virus compared with calves unexposed to pathogens 
 Control  Infected  P Values 
Gene PRE 12H 24H  PRE 12H 24H SEM TRT TIME TRT × TIME 
   
 
  
 
     
BACE1 -0.39 -0.31 -1.43  -0.69 2.96 2.52 1.25 0.03 0.35 0.23 
            
FADS2 1.86 -4.40 -9.10  4.60 -54.66 -181.13 43.93 0.05 0.10 0.15 
            
S100A8 0.04a -1.40a 0.62a  -0.02a 43.99b 42.13b 7.37 < 0.001 < 0.01 < 0.01 
            
a,b
 Values with different superscripts are considered significantly different (P < 0.05). 
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Figure 4.1. Categories of genes up-regulated in liver tissue of beef calves following 24 hours of joint infection with BVDV and M. 
haemolytica. 
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Figure 4.2. Categories of genes down-regulated in liver tissue of beef calves after 24 hours of joint infection with BVDV and M. 
haemolytica. 
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CHAPTER V 
 
Gene expression changes in muscle and liver tissues of growing beef heifers at the 
time of treatment for bovine respiratory disease 
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ABSTRACT 
Bovine respiratory disease (BRD) has been shown to have deleterious consequences on 
beef carcass characteristics by decreasing muscle and fat content. The objective of this 
study was to evaluate the effects of the number of BRD treatments on gene expression in 
muscle and liver tissues. We used 24 beef heifers that were identified as having 
nonspecific BRD. Muscle and liver biopsy samples were taken from untreated calves 
(0X), and calves treated once (1X), twice (2X), or thrice (3X) for BRD. RT-PCR was 
performed to evaluate gene expression. Fold change was determined using the ∆CT 
method and was analyzed using the MIXED procedure. Orthogonal contrasts were 
performed to compare untreated and treated calves and for linear and quadratic effects. 
We observed differences (P < 0.10) among treatments for ADIPOR1, BAD, FBXO32, and 
GLUL in muscle tissues with inductions of 3.9, 3.6, 4.2, and 8.7 fold, respectively, in the 
treated calves compared to the controls (P ≤ 0.01). Each of these genes increased in 
expression in a linear manner with number of treatments (P < 0.05). In liver tissues, 
significant differences were observed in FASN and S100A8 expression (P < 0.10). FASN 
expression was reduced 6.8 fold in treated vs. control calves (P = 0.02) and had a 
quadratic response to number of treatments such that 1X, 2X, and 3X were suppressed 
10.2, 4.0, and 6.1 fold, respectively, compared to 0X (P = 0.10). S100A8 was increased 
21.3 fold in 2X (P < 0.10). Results from the present experiment indicate gene expression 
changes in muscle characteristic of muscle atrophy and impaired growth signaling. These 
gene expression changes worsen with increased numbers of times treated for BRD. Gene 
expression changes in the liver, suggest a suppression of de novo fatty acid synthesis and 
inflammation. 
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INTRODUCTION 
 Bovine respiratory disease (BRD) continues to be the most prevalent ailment of 
cattle leading to detrimental effects on growth and performance (Snowder et al., 2006). 
Several groups have observed decrements in average daily gain (ADG) that approach 
60% during the early feeding phase in calves treated for undifferentiated BRD 
(Montgomery et al., 2009; Schneider et al., 2009; Holland et al., 2010). This decrease in 
performance resulted in lighter final body weights and hot carcass weights when cattle 
were fed similar days on feed (Gardner et al, 1999; Schneider et al., 2009; Garcia et al., 
2010).  
While researchers have observed dramatic decreases in animal performance early 
in the feeding period, there is evidence to suggest that calves treated multiple times for 
BRD may be able to compensate for losses by increasing ADG and feed efficiency during 
the finishing phase by as much as 25% so that by the end of feeding, final body weights 
were similar to untreated calves (Montgomery et al., 2009; Schneider et al., 2009; 
Holland et al., 2010). In fact, some performance parameters actually increased linearly 
with the number of times treated except in chronically morbid calves (Montgomery et al., 
2009; Holland et al, 2010). Indeed, researchers have found a significant correlation 
between the number of treatments and performance outcomes (Babcock et al., 2009). 
 However, little is known about the molecular basis for the disease outcomes in 
cattle with BRD. Previous research from our lab involving gene expression profiling of 
muscle and liver tissues in calves experimentally challenged with bovine viral diarrhea 
virus and Mannheimia haemolytica suggested inflammation in both tissues with atrophy 
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in muscle and lipidosis in liver (unpublished data). Based upon these previous results, we 
sought to examine the effects of the number of treatment events on the gene expression 
changes in these tissues in calves identified with clinical BRD. 
MATERIALS AND METHODS 
Cattle Management 
All procedures performed with the animals were approved by the Institutional 
Animal Care and Use Committee at Oklahoma State University (Protocol # AG0714). 
Twenty four commercial beef heifers (258.5 ± 29.2 kg) were selected from a larger study 
conducted at the Willard Sparks Beef Research Center that began in September 2009 
(Wahrmund et al., 2011). Identification of calves for treatment was based upon 1) clinical 
signs of BRD by a trained professional using the following characteristics: lethargy, 
gauntness, altered gait, and nasal or ocular discharge; and/or 2) identification of sustained 
ruminal temperature elevation above 41° C. Calves received antimicrobial treatment if 
rectal temperature was ≥ 41° C or if calves were deemed severe or moribund as assessed 
by visual classification. Calves received tulathromycin (Draxxin; Pfizer Animal Health; 
Madison, NJ) at first treatment, enrofloxacin (4.5 ml/45.4 kg body weight; Baytril; Bayer 
Animal Health; Shawnee Mission, KS) at second treatment, and two doses of ceftiofur 
(2.0 ml/45.4 kg body weight; Excenel; Intervet/Schering Plough; Desoto, KS) at 48 h 
intervals for third treatment. Biopsy samples were taken for 3X at initial dosing for the 
third treatment. 
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Biopsy Procedures 
Muscle and liver biopsies were taken at the time of treatment for calves at first 
(1X;n = 6), second (2X; n = 6), and third (3X; n = 6). A 10 day wait period was observed 
after sampling of all sick calves to insure that calves in the control group were indeed 
healthy (0X; n = 6). Calves were restrained while standing during biopsy procedures. 
Surgical areas were clipped and the sites were aseptically prepared by scrubbing thrice 
with iodine soap, ethanol (75%) solution, and rinsed with sterile water; scrubbing was 
performed in a circular motion beginning at the center of the focal area and moving 
outward. Following the third wash, the area was cleansed with iodine solution using the 
same scrubbing motion. Next, a local anesthetic (4 to 10 ml of lidocaine 2%) was injected 
subcutaneously in both sites and into the intercostal space for the liver area; incisions 
were made following a 3 to 5 minute pause to allow sufficient desensitization. 
Muscle biopsy procedures were performed similarly to those described by Meijer 
and coworkers (1995). Samples were removed from a small area (5 x 5 cm) 
approximately 10 cm caudal to the last rib and approximately 8 cm lateral to the 
vertebrae on the right side. A stab incision (1 to 2 cm) using a scalpel blade was made 
through the skin, a sterile Bergstrom biopsy trochar (7 mm in diameter) was inserted into 
the longissimus dorsi muscle and 100 to 200 mg of tissue was removed, placed in a 
sterile vial, and immediately placed in liquid nitrogen (Dunn et al., 2003; Pampusch et 
al., 2003). Samples were stored at -80oC until lab analysis was performed. 
Liver biopsy sampling was performed similar to that described by Swanson et al., 
2000. An area on the right cranial abdominal cavity was prepared in such a way as to 
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surround the intercostal space of the 11th and 12th ribs. Subsequently, the biopsy needle 
[12-gauge × 10 cm with a penetration depth of 22 mm; Bard® Monopty® Biopsy 
Instrument (C. R. Bard, Inc., Covington, GA)] was advanced through the intercostal 
muscle on the caudal side of the 11th rib, through the peritoneum and diaphragm, and into 
the liver. Upon collection of the sample, the instrument was retracted and the specimen 
was placed in a sterile vial and immediately placed in liquid nitrogen. All samples were 
stored at -80º C until analysis was performed. 
RNA Isolation 
 Tissue samples were placed in 1-2 ml TRIzol ReagentTM (Invitrogen; Carlsbad, 
CA) and homogenized 15-30 s on ice (4o C). Supernatant was collected and phenol-
chloroform extraction was performed to isolate total RNA according to the 
manufacturer’s protocol with minor modifications. Briefly, samples were allowed to 
stand at room temperature (23o C) for 5 min. to promote protein dissociation. Chloroform 
was added to the samples at 0.2 ml per 1 ml of TRIzol reagent used and samples were 
allowed to stand for 10 min. at room temperature. Samples were then centrifuged at 
12,000 x g for 15 min. in 4oC. The aqueous phase was collected and RNA precipitated by 
adding an equal volume of absolute isopropanol. Samples were kept overnight in -20 o C 
followed by a second centrifugation as previously mentioned. The supernatant was 
discarded and the RNA pellet was washed with 75% ethanol and centrifuged at 12,000 x 
g for 2 min. The ethanol supernatant was removed and samples were allowed to dry at 
room temperature. RNA was suspended using diethylpyrocarbonate treated water (42o C) 
and concentration determined by spectrophotometry (NanoDrop ND-1000; Thermo 
Scientific; Wilmington, DE). Agarose gel (1%) electrophoresis was used to determine 
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RNA integrity. Samples were treated with DNase (DNase I, Amplification Grade; 
Invitrogen Corp., Carlsbad, CA) to eliminate contamination from genomic DNA 
according to the manufacturer’s protocol. 
Reverse Transcription Polymerase Chain Reaction 
 Reverse transcription was performed with 1800 ng RNA using QuantiTect reverse 
transcription kit (Qiagen Inc.; Valencia, CA) according to the manufacturer’s protocol. 
Quantitative PCR was conducted with 90ng cDNA using the PerfeCTa® SYBR® Green 
FastMix® Kit (Quanta Biosciences Inc.; Gaithersburg, MD) according to the following 
reaction protocol: initial denaturation: 95ºC for 2 min. 30s; denaturation: 95ºC for 10s, 
annealing at 58ºC for 30s, and extension at 72ºC for 30s (forty cycles). The reaction was 
performed and fluorescent intensity measured using the BioRad MyiQ™ Real Time PCR 
Detection System (Bio-Rad Laboratories, Inc.; Hercules, CA). Amplification efficiency 
was assessed by performing qPCR with a standard curve of serial dilutions of cDNA 
(Table 5.1). Primer sequences are presented in Table 5.1. 
Data Analysis 
The experiment was conducted in a completely randomized design with number 
of times treated (TRT) as the main effect with animal(TRT) used as the residual error. 
Orthogonal contrasts were performed to compare untreated and treated calves as well as 
the linear and quadratic effects of increasing numbers of treatment. Data from RT-PCR 
was analyzed as the difference (∆Ct) between the threshold cycle (Ct) for 18S and that for 
gene of interest. Fold change values were analyzed using the MIXED procedure (SAS v. 
9.2, SAS Institute Inc.; Cary, NC). Fold change was determined using relative 
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quantification, otherwise known as the 2-∆∆CT method (Livak and Schmittgen, 2001). 
Gene expression was considered significantly different at P < 0.10. 
RESULTS 
Muscle Samples 
 Muscle biopsy samples were collected to evaluate the differences in gene 
expression of selected genes involved in muscle growth and development. There were 
significant differences among the treatment groups for ADIPOR1, FBXO32, BAD, and 
GLUL (P < 0.10; Table 5.2). ADIPOR1 encodes for the adiponectin receptor 1 and 
involved in signal transduction for growth promotion and its expression can be influenced 
by hormones such as adiponectin, insulin, and glucocorticoids. In this experiment, 
ADIPOR1 was significantly induced 3.9-fold on average in the treated calves compared 
to the healthy control heifers (P < 0.01). There was a linear increase in ADIPOR1 with 
increasing number of treatments with and an initial 3.3-fold increase in 1X compared to 
0X and approximately 0.6-fold decrease in transcripts with each additional treatment 
above 1X (P = 0.01). FBXO32 encodes for atrogin 1, an E3 ubiquitin ligase, involved in 
the ubiquitin-proteasome degradation of proteins. Its expression was higher in the treated 
group of calves compared to the healthy controls (4.2-fold; P = 0.01) and increased 
linearly as the number of treatments increased with a 2.8-fold induction in 1X and 
increasing further to 4.9-fold up-regulation in 2X and 3X (P < 0.01). BAD transcribes 
BCL2-associated agonist of cell death protein and is involved in apoptotic signaling. 
Transcription of BAD was induced an average of 5.2 fold in the treated heifers relative to 
the control heifers (P < 0.01). Its expression increased linearly with an increase in the 
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number of treatment events, such that expression in 1X, 2X, and 3X was 4.0, 4.4, and 
7.4-fold, respectively, in comparison with 0X (P < 0.001). Lastly, GLUL is the gene for 
glutamine synthetase, an ATP-dependent enzyme that ligates ammonia to glutamate. It is 
a sensitive indicator of muscle atrophy. Expression of GLUL was induced an average of 
8.7-fold in treated calves compared to healthy calves (P = 0.01). The greatest suppression 
occurred in the 2X group displaying 10.1-fold increase in expression compared to 0X, 
while 1X and 3X expression was 7.7 and 8.3-fold, respectively; yet a significant linear 
relationship existed among the groups (P = 0.03). 
Liver Samples 
 Liver biopsy samples were taken to investigate the changes in gene expression as 
a result of prolonged BRD infection. We observed significant differences among the 
treatments for FASN and S100A8 (P < 0.10, Table 5.3). We observed a significant 
suppression of FASN in treated calves compared to untreated calves (-6.78-fold, P = 0.02) 
There was a 21-fold up-regulation of S100A8 in 2X compared to 0X, but differences 
between the control versus treated calves. There were also numeric differences for acetyl 
CoA carboxylase (ACACA) transcription between the treatment groups (P = 0.11). These 
differences resulted from a numeric decrease in ACACA expression in 1X and 3X heifers 
(+39.7 and +12.3-fold, respectively), Additionally, there was a trend for a decrease in 
fatty acid desaturase 2 (FADS2) expression in treated calves compared with controls (-
52.8 fold, P = 0.11).  
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DISCUSSION 
 Results from our experiment indicate a linear expression of ADIPOR1, the gene 
that encodes for adiponectin receptor 1, as the number of treatments for BRD increases in 
beef heifers. This receptor is most abundantly expressed in skeletal muscle and mediates 
the effects of adiponectin, an adipokine (Yamauchi et al., 2003). The reason for the 
increased expression of ADIPOR1 in the current experiment is difficult to explain. 
Glucocorticoids, which are often increased during morbidity, are capable of decreasing 
serum adiponectin levels (Shi et al., 2010). Inflammatory signaling may also play an 
indirect role in ADIPOR1 expression. Researchers have found that TNF-α can decrease 
adiponectin secretion by adipocytes and alter serum concentrations of the adipokine 
(Degawa-Yamauchi et al., 2005; Lo et al., 2007). Therefore, it could be that a 
combination of stress and inflammation induced with BRD morbidity may result in 
decreased adiponectin levels in the blood and thereby suppress ADIPOR1 expression in 
longissimus dorsi muscle tissues. However, expression of ADIPOR1 has been shown to 
increase in response to stimulation by globular adiponectin in myotubes from lean human 
subjects (McAinch et al., 2006).In addition, ADIPOR1 levels may be affected by insulin 
levels, however the data is equivocal. Research conducted using murine myocytes in vitro 
demonstrated insulin having a suppressive effect on ADIPOR1 expression (Staiger et al., 
2004; Tsuchida et al., 2004). On balance, in human subjects, ADIPOR1 expression has 
been positively correlated with circulating insulin levels (Debard et al., 2004; Staiger et 
al., 2004). Infusion of insulin increased ADIPOR1 levels 2-fold in human skeletal muscle 
(Debard et al., 2004). The effect of insulin may play a role in BRD related induction of 
ADIPOR1, but it is unclear. Montgomery et al (2009) observed a linear decrease in 
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plasma glucose concentrations as number of treatments for BRD increased in feedlot 
heifers. Even though that group did not evaluate insulin levels, one may assume that with 
decreased glucose content insulin levels would concomitantly decrease. It may be that 
calves diagnosed with BRD in the present experiment decreased feed intake, thereby 
lowering insulin levels and its suppressive effects on ADIPOR1 relative to healthy calves. 
It may be that a combination of stress, inflammation, and alterations in feed intake 
contribute to the changes in ADIPOR1 expression seen in the beef heifers used in the 
current experiment.  
 We previously identified a network of genes that centered upon nuclear factor κB 
(NF-κB; data unpublished) in muscle from calves experimentally challenged with BRD 
pathogens. Nuclear factor κB signaling is known to mediate muscle catabolism in 
response to pro-inflammatory cytokines via the ubiquitin-proteasome pathway. To 
evaluate molecular markers of muscle degradation, we choose to evaluate the gene 
expression of FBXO32, which encodes for atrogin-1, an E3 ubiquitin ligase. Atrogin-1 
and other atrogenes are tissue-specific and are often increased in atrophying muscle 
(Bodine et al. 2001; Gomes et al., 2001). Inflammatory ligands such as LPS, 
dexamethasone, and TNF-α have been shown to stimulate expression of these atrogenes 
with long-term effects, but interestingly inhibition of these pathways does not mitigate 
their expression (Frost et al., 2007). This group found that the anabolic hormone, insulin-
like growth factor-1, could suppress atrogin-1 (Frost et al., 2007). In our study, we found 
a linear increase in FBXO32 expression with calves treated two or more times having a 
near 5-fold induction of the gene. This would suggest that proteasomal muscle 
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degradation is increased in the muscle tissues of beef heifers treated multiple times for 
undifferentiated BRD. 
 This hypothesis is supported by the expression change in GLUL. This gene 
transcribes glutamine ammonia ligase, which is commonly referred to as glutamine 
synthetase. We found a linear increase in GLUL expression over 10-fold in calves treated 
twice for BRD. Inflammation is known to deplete intracellular glutamine content and 
increase expression of GLUL to ligate free ammonia from amino acid catabolism to 
glutamate. This is a hallmark of muscle atrophy (Calder and Yaqoob, 1999; Stipanik and 
Watford, 2000). Stimulation of skeletal muscle cell lines with TNF-α increased GLUL 
expression within hours and peak glutamine synthetase activity at 48 hours post-
challenge (Chakrabarti, 1998). The stimulation of GLUL transcription in our study 
indicates that muscle atrophy is present and is increased in calves with more protracted 
BRD symptoms. 
 Lastly we found BAD expression to also be induced linearly with increasing 
numbers of treatment events for BRD calves. BAD encodes for the BCL2-associated 
agonist of cell death protein. This protein is a member of the B cell lymphoma-2 (BCL-2) 
family of proteins which are a group of oncogenes involved in cell survival. BCL-2 
protein has been detected in rodent and human inflammatory myopathies, but absent in 
normal muscle tissues (Tews et al., 1997; Behrens et al., 1997). Further in vitro research 
revealed that increased expression of BCL-2 plays a role in myogenesis and protects 
muscle cells from apoptotic signaling (Dominov et al., 1998). In fact, this latter group 
observed in C2C12 murine muscle cell cultures that some BCL-2 expressing cells 
subjected to pro-apoptotic stimuli were able to survive and proliferate upon removal of 
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those stimuli (Dominov et al., 1998). Research has shown that BAD binds to BCL-2 
essentially blocking pro-survival signaling and sensitizes cells to apoptosis (Zong et al., 
2001; Kim et al., 2006). In addition, signaling with growth factors, such as platelet 
derived growth factor and insulin-like growth factor-1, lead to activation of protein 
kinase B/Akt activation which phosphorylates BAD and abrogates its apoptotic effects 
(Datta et al., 1997; Song et al., 2005). The increase in BAD mRNA could lead to 
increased BAD protein to promote apoptosis in existing myofibers and delay repair 
signaling by BCL-2 in myoblasts. 
 As expected, data from the present study indicate that muscle tissues from heifers 
treated multiple times for BRD are in a state of chronic inflammation. Genes involved in 
protein degradation and apoptosis are up-regulated allowing for the possibility that calves 
diagnosed with BRD have muscle atrophy proportional to the chronic nature and severity 
of infection. This is congruent with previous finding that calves treated multiple times for 
BRD have decreased weight gain and muscle accretion than calves not treated for BRD 
particularly during the early feeding phase (Gardner et al., 1999; Montgomery et al., 
2009; Holland et al., 2010). It is of interest to note that three of the genes evaluated are a 
part of the Akt signal transduction pathway. Adiponectin receptor 1 mediates adiponectin 
signaling to the Akt pathway (Yamauchi et al., 2003) while atrogin-1 (Sandri et al., 2004) 
and BAD (Song et al., 2005) are downstream targets of this signal transduction pathway. 
Our results suggest that Akt signaling is being suppressed in muscle tissue of calves 
during treatment for BRD. Researchers have demonstrated Akt signaling pathway is 
involved in protein synthesis and that stimulation of such can enhance translation 
initiation, but such signaling is blunted under inflammatory conditions (Lang et al., 
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2007). With pivotal effects in regulating protein synthesis and catabolism, further 
investigation into the role of Akt signaling in bovine muscle during morbidity may reveal 
therapeutic interventions capable of moderating the muscle loss associated with BRD. 
 We had previously identified gene targets that were affected during the acute 
phase response on the liver of steers experimentally challenged with M. haemolytica and 
bovine viral diarrhea virus. These genes were indicative of inflammation and 
dyslipidemia. Based upon those results, we sought to identify molecular changes in 
hepatic tissues in heifers with clinical BRD; however, because of variability in gene 
expression of the heifers in the study, we were unable to definitively characterize the 
prolonged effects of BRD on liver gene expression. There is evidence from the present 
study that S100A8 expression is increased more than 20-fold in 2X calves compared with 
the other treatment groups. S100A8 encodes S100 calcium binding protein A8 and acts as 
a chemoattractant for neutrophils (Xu and Geczy, 2000; Nacken et al., 2003; Gebhardt et 
al., 2006). It has been shown to increase during liver inflammation and promotes 
neutrophil infiltration, but its expression is inconsistent with the expression of other 
hepatic genes where we observed less effects as treatment number increased compared 
with healthy calves. 
The magnitude of changes in gene expression seen in the present experiment in 
the liver, lend credence to our hypothesis that inflammation is continuing to affect lipid 
metabolism. Numerical differences in ACACA, SCD (stearoyl-CoA desaturase), and 
FASN expression suggest that fatty acid synthesis is inhibited in the liver during BRD 
infection; indeed there were significant differences between control and treated calves for 
FASN expression (P = 0.02). This is somewhat unexpected as previous research has 
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established that hyperlipidemia and increased fatty acid synthesis are characteristics of 
bacterial infections and cytokine stimulation (Feingold and Grunfeld,. 1986; Grunfeld 
and Feingold, 1991). However, the effects on gene expression are more varied. One 
group observed an increase in FASN transcripts in response to septic levels of TNF-α 
challenge in mice (Endo et al., 2007). On the other hand, lower doses of the cytokine and 
LPS are known to suppress transcription of ACACA and FASN by nearly 8-fold in 
previously fasted and re-fed mice, thereby effectively blocking the typical increase in 
these genes in realimentation (Feingold et al., 2011). In addition, gene expression 
profiling of liver tissues in mice injected with lipopolysaccharide showed decreased 
expression of genes involved in fatty acid synthesis and oxidation; notably FASN was 
suppressed more than 4-fold (Yoo and Desiderio, 2003).  
Other factors may contribute to the changes in FASN expression in addition to 
inflammatory signaling. Nutritional effects have demonstrated effects on FASN synthesis. 
Fasting is known to suppress fatty acid synthase gene expression in rodents (Gosmain et 
al., 2005; Morgan et al., 2008). This suppression is mediated in part as a result of 
decreased blood glucose which works through insulin sensitization to positively regulate 
FASN expression (Prip-Buus et al., 1995). Heifers treated multiple times for 
undifferentiated BRD display a linear decrease in glucose concentrations in the blood as 
the number of times for treatment increases, but there is no reported measurement of 
insulin levels during such conditions (Montgomery et al., 2009). It has also been shown 
that calves treated for BRD have decreased feed intake (Holland et al., 2010). This 
combination of nutritional consequences of BRD morbidity may explain the decreased 
expression of FASN expression observed in the present experiment. 
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It may also be that increased fat mobilization, as a result of systemic inflammation 
and negative energy balance resulting from inappetence, leads to fatty acid accumulation 
in the liver thereby suppressing de novo fatty acid synthesis by a negative feedback 
mechanism. Interestingly this effect is mediated by polyunsaturated fatty acids (PUFA) 
which are demonstrated to suppress expression of several transcription factors and genes 
involved in lipogenesis (Pégorier et al., 2004). Omega-6 and omega-3 fatty acids are 
particularly effective in reducing FASN transcripts with some reductions approaching 8-
fold (Blake and Clarke, 1990; Clarke et al., 1990a; Clarke et al., 1990b). Even though the 
history of these heifers was unknown, it may be that the linear improvement in FASN 
expression was a result of the decline in PUFA content in peripheral fat depots. Duckett 
et al. (1993) showed that calves coming off grass pastures have PUFA levels that steadily 
decline over time on feed with significant decline observed at 28 days. This could also be 
due to increased health status of these calves; it is possible that the most severe morbidity 
occurred at 1X and the calves at 3X are beginning to convalesce, however results from 
muscle tissue suggest an exacerbation of morbidity. The gene expression profile observed 
in the current study is similar to that observed in ketotic and/or energy deficient dairy 
cows (Loor et al., 2007; McCarthy et al., 2010). Dairy cows experiencing energy deficit 
have suppressed expression of FADS2 which was also observed in the present experiment 
(Loor et al., 2007; McCarthy et al., 2010). This series of genes that are down-regulated 
indicates a generalized suppression in de novo fatty acid synthesis as a result of energy 
deficit. This suppression of fatty acid synthesis explains the decreased fat content that 
BRD treated calves have in subcutaneous, intramuscular, and perirenal fat depots. 
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In summary results from the present experiment show that gene expression 
changes in muscle tissues in heifers treated for BRD under field conditions are such that 
muscle atrophy is increased in a linear fashion as the number of treatment events 
increases. This indicates that BRD can have prolonged and detrimental consequences to 
muscle protein accretion such that proteolysis and inhibition of growth signaling are a 
result of chronic BRD infection. While the muscle gene expression was consistent, liver 
gene expression was more variable, but there is an indication that inflammation is present 
in the liver of calves treated 2X for BRD and that fatty acid metabolism is modified. 
FASN is the enzymatic regulator of fatty acid synthesis for a protracted period of time 
and its suppression demonstrates an overall decline in fatty acid synthesis, but shows 
improvement in expression levels as the treatment progresses. These results demonstrate 
the long term consequences of BRD and further underscore the need for early 
intervention and treatment of morbid calves. 
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Table 5.1. Primer sequences, amplification efficiencies, and standard curve r2 values 
Gene Forward Sequence Reverse Sequence Efficiency r2 
18S TTCGAACGTCTGCCCTATCAA GATGTGGTAGCCGTTTCTCAGG 92.4% 0.998 
ACACA TGCACGGCTGACTGGAGTTGA TGTCCGTCTTCAGGTCGCGT 103.4% 0.971 
ADIPOR1 CCTCCCTCACCCCTGTCCTGA AGGCCCGAGAAAGATGGGACCAG 100.3% 0.922 
BAD TCCGGTGTGTGCGAGGACCA TTCCGGCAGGTAAGGGCGGA 93.1% 0.947 
FADS2 GGAACCATCGCCACTTCCAGCA TCTTGCCGTACTCAATGGGCTGC 103.7% 0.972 
FASN ACCCCACAACTGCCATCCACCT TGGCCTGTGTTGCCTTCGGA 95.7% 0.968 
FBXO32 CCGTGAGGCTTGATGTCAGCT GGGTTTTATCCGGGCCATGC 99.0% 0.982 
GLUL ACATTGAGGAGGCCATTGAG TTGATGTTGGAGGTTTCGTG 100.9% 0.975 
S100A8 AGGATGCGGACACTTGGTTCAAA GCCCACCTTTATCACCAGCACG 97.4% 0.994 
SCD TCACATTGATCCCCACCTGCAA TCGGTGACTCCACAGGCGAT 90.6% 0.987 
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Table 5.2. Least squares means of fold change of genes in muscle of beef heifers with bovine respiratory disease at time of treatment 
 Number of Times Treated  P Values 
Gene OX 1X 2X 3X SEM TRT 
UNTREATED 
VS. TREATED LINEAR 
   
 
     
ADIPOR1 0.42 3.30 3.89 4.37 1.02 0.05 < 0.01 0.01 
         
BAD -0.26 3.97 4.36 7.37 1.19 < 0.001 < 0.001 < 0.001 
         
FBXO32 0.29 2.84 4.89 4.86 1.20 0.04 0.01 < 0.01 
         
GLUL 0.34 7.66 10.11 8.35 2.56 0.06 0.01 0.03 
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Table 5.3. Least squares means of fold change of genes in liver of beef heifers with bovine respiratory disease at time of treatment 
 Number of Times Treated  P Values 
Gene OX 1X 2X 3X SEM TRT 
UNTREATED 
VS. TREATED LINEAR QUADRATIC 
   
 
      
ACACA 0.15 -39.73 -1.03 -12.25 12.81 0.11 0.19 0.98 0.22 
          
FADS2 0.05 -64.27 -40.83 -53.33 31.06 0.42 0.12 0.27 0.36 
          
FASN 0.39 -10.19 -4.03 -6.13 2.72 0.06 0.02 0.22 0.10 
          
S100A8 -0.17 -0.08 21.27 1.25 7.74 0.09 0.35 0.40 0.16 
          
SCD 0.56 -18.05 -14.22 -13.15 9.88 0.50 0.14 0.34 0.28 
          
 
 105 
CHAPTER VI 
 
Summary Review of Gene Expression changes in Muscle and Liver Tissue of 
Growing Beef Calves with Bovine Respiratory Disease 
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 Bovine respiratory disease continues to be the most prevalent and costly disease 
facing beef cattle in North America. Economic losses from the disease complex result not 
only from direct costs to the producer such as medication, labor, and mortality losses, but 
also extend indirect costs due to decreased animal weight gain, and decreased carcass 
value stemming from decreased marbling and ribeye area which cut into producers’ 
profits. 
 In these experiments we sought to characterize gene expression changes in muscle 
and liver tissues during acute and chronic illness associated with BRD. Findings from 
these experiments showed that muscle tissue was less affected early in infection than 
liver tissues. However, we observed that gene expression in muscle over a more 
prolonged period of illness changed to indicate that muscle tissue is being catabolized. 
Protein degradation in muscle is used to supply amino acids for the immune response. 
Therefore, chronic morbidity can lead to significant reduction in muscle protein and 
invariably muscle content of the calf explaining in part the decreased muscle mass and 
yield that results from BRD infection in beef cattle. 
 In liver tissues, we observed an early and significant response to BRD infection. 
Significant inflammatory markers were observed in the liver indicative of immune cell 
infiltration and activity. In fact, in a companion study to these, our laboratory group 
observed significant increases in leukocytes and neutrophils within the first day of 
infection of BRD. In addition, the liver decreases expression of genes for fatty acid 
metabolism and specifically we observed a significant reduction in transcription of genes 
involved in fatty acid synthesis. This indicates that early during infection, the liver is 
decreasing synthesis of new fatty acids possibly due to mobilization from fatty acids from 
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peripheral tissues. These mobilized fatty acids are stored in the liver as an alternative 
energy source to carbohydrates to fuel the survival of the animal during acute infection 
when appetite is typically suppressed. On the other hand, it appears that the dramatic 
modifications that occurring in the liver during acute infection are attenuated with more 
prolonged infection. We observed that expression of inflammatory genes in the liver was 
only slightly changed over a prolonged period of infection. We further observed that 
expression of genes in fatty acid metabolism indicated less suppression of fatty acid 
synthesis as the length of morbidity increased. This may well result from a decrease in 
the amount of fatty acids mobilized from the periphery to the liver which could result in 
fatty liver. Utilization of these early mobilized fatty acids for energy by the calf over 
prolonged morbidity would lead to decreased fatty acid content stored the liver. This may 
explain the attenuation of the suppression of fatty acid metabolism. 
 Overall, it appears that muscle tissues are less affected by acute BRD infection 
than are liver tissues in growing beef calves. However, atrophy of muscle and depression 
of fatty acid synthesis in calves with BRD infection may explain the decreases in muscle 
yield and marbling often associated with calves treated from the disease. 
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Scope and Method of Study:  
 
Bovine respiratory disease is the most costly ailment in beef cattle. It leads to 
decreased carcass quality and profitability. It has been shown to decrease muscle 
and fat accretion. Research in other species has identified several gene targets in 
muscle and liver whose expressions are changed in response to inflammation, but 
there are few studies that address these molecular mechanisms in cattle. The 
objectives of our studies were to collect muscle and liver biopsy samples from 
beef cattle with bovine respiratory disease under experimental and field 
conditions and identify gene targets to understand the deleterious effects of 
morbidity on carcass quality and metabolism. 
 
Findings and Conclusions:   
 
We found that bovine respiratory disease modified gene expression in muscle 
tissue to indicate that atrophy was occurring. Several of the genes identified were 
involved in the Akt/protein kinase B signaling pathway and indicated a resistance 
to growth stimulation and pro-apoptosis. Expression of genes encoding for 
adiponectin receptor 1 (ADIPOR1), atrogin-1 (FBXO32), BCL2-associated 
agonist of cell death protein (BAD), glutamine synthetase (GLUL), and 
thioesterase superfamily member 4 (THEM4) were modified in muscle tissues in 
response to bovine respiratory disease conditions. In the liver, we found fatty acid 
metabolism and inflammation to be most affected. Expression of genes encoding 
for acetyl-CoA carboxylase (ACACA), β-site APP-cleaving enzyme 1 (BACE1), 
fatty acid desaturase 2 (FADS2), fatty acid synthase (FASN), and S100 calcium 
binding protein A8 (S100A8) were affected by bovine respiratory disease. The 
molecular targets identified in the muscle and liver help to explain the loss of 
muscle and fat that is often associated with this disease and future research is need 
to address way to manipulate their expression in ways to mitigate these losses. 
